Gene Symbol | Gene ID | Gene Info |
---|---|---|
Elf1
|
ENSMUSG00000036461.9 | E74-like factor 1 |
Elf2
|
ENSMUSG00000037174.12 | E74-like factor 2 |
Etv2
|
ENSMUSG00000006311.8 | ets variant 2 |
Elf4
|
ENSMUSG00000031103.6 | E74-like factor 4 (ets domain transcription factor) |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr14_79535326_79536502 | Elf1 | 20216 | 0.142942 | 0.80 | 1.7e-14 | Click! |
chr14_79515332_79515648 | Elf1 | 184 | 0.939169 | 0.75 | 4.6e-12 | Click! |
chr14_79515651_79516545 | Elf1 | 400 | 0.830653 | 0.72 | 6.3e-11 | Click! |
chr14_79518977_79519658 | Elf1 | 3619 | 0.204922 | 0.71 | 1.5e-10 | Click! |
chr14_79516555_79517268 | Elf1 | 1213 | 0.434612 | 0.66 | 7.7e-09 | Click! |
chr3_51335343_51335553 | Elf2 | 5113 | 0.126883 | 0.64 | 4.9e-08 | Click! |
chr3_51333199_51333572 | Elf2 | 7176 | 0.118293 | 0.56 | 3.9e-06 | Click! |
chr3_51348770_51349056 | Elf2 | 8250 | 0.109990 | 0.50 | 5.3e-05 | Click! |
chr3_51335609_51335839 | Elf2 | 4837 | 0.128819 | 0.43 | 6.3e-04 | Click! |
chr3_51338760_51339019 | Elf2 | 1672 | 0.242910 | 0.29 | 2.3e-02 | Click! |
chrX_48424911_48425565 | Elf4 | 28931 | 0.151866 | 0.79 | 3.6e-14 | Click! |
chrX_48433315_48433759 | Elf4 | 20632 | 0.169925 | 0.74 | 2.2e-11 | Click! |
chrX_48451824_48452232 | Elf4 | 2141 | 0.308329 | 0.66 | 7.4e-09 | Click! |
chrX_48452991_48453840 | Elf4 | 754 | 0.658746 | 0.65 | 1.5e-08 | Click! |
chrX_48424437_48424875 | Elf4 | 29513 | 0.150509 | 0.58 | 1.1e-06 | Click! |
chr7_30635865_30636813 | Etv2 | 487 | 0.530256 | 0.34 | 8.2e-03 | Click! |
chr7_30633440_30635827 | Etv2 | 1219 | 0.196563 | 0.33 | 1.0e-02 | Click! |
chr7_30640362_30640513 | Etv2 | 4585 | 0.069463 | 0.13 | 3.4e-01 | Click! |
chr7_30632550_30632789 | Etv2 | 3183 | 0.080942 | 0.05 | 6.8e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr17_84180639_84182724 | 32.53 |
Gm36279 |
predicted gene, 36279 |
4075 |
0.18 |
chrX_170676003_170677019 | 26.58 |
Asmt |
acetylserotonin O-methyltransferase |
3867 |
0.35 |
chr7_45523041_45524800 | 26.40 |
Ppp1r15a |
protein phosphatase 1, regulatory subunit 15A |
151 |
0.85 |
chr11_117781108_117781521 | 24.08 |
Tmc6 |
transmembrane channel-like gene family 6 |
370 |
0.6 |
chr19_7018033_7019009 | 23.62 |
Fermt3 |
fermitin family member 3 |
824 |
0.38 |
chr1_136945385_136947968 | 23.28 |
Nr5a2 |
nuclear receptor subfamily 5, group A, member 2 |
2497 |
0.34 |
chr5_30913519_30915234 | 23.05 |
Emilin1 |
elastin microfibril interfacer 1 |
637 |
0.48 |
chr9_107982030_107984233 | 22.95 |
Gm20661 |
predicted gene 20661 |
38 |
0.54 |
chr12_108765285_108766682 | 22.42 |
Gm33682 |
predicted gene, 33682 |
3013 |
0.15 |
chr8_84703616_84705950 | 22.15 |
Nfix |
nuclear factor I/X |
2933 |
0.13 |
chr8_25542987_25545804 | 21.31 |
Gm16159 |
predicted gene 16159 |
9165 |
0.11 |
chr8_68205432_68207408 | 21.19 |
Psd3 |
pleckstrin and Sec7 domain containing 3 |
363 |
0.91 |
chr9_107975554_107976970 | 21.11 |
Uba7 |
ubiquitin-like modifier activating enzyme 7 |
46 |
0.91 |
chr7_143007094_143009025 | 20.91 |
Tspan32os |
tetraspanin 32, opposite strand |
26 |
0.96 |
chr15_12193885_12195324 | 20.66 |
Gm49240 |
predicted gene, 49240 |
2015 |
0.19 |
chr11_87756102_87757558 | 20.53 |
Mir142 |
microRNA 142 |
34 |
0.59 |
chr3_79885722_79887545 | 20.26 |
Gm36569 |
predicted gene, 36569 |
173 |
0.83 |
chr4_154024404_154026596 | 20.19 |
Smim1 |
small integral membrane protein 1 |
116 |
0.93 |
chr5_64810297_64813272 | 20.13 |
Klf3 |
Kruppel-like factor 3 (basic) |
555 |
0.71 |
chr7_44479611_44481283 | 20.00 |
5430431A17Rik |
RIKEN cDNA 5430431A17 gene |
4070 |
0.08 |
chr2_105125289_105128976 | 19.83 |
Wt1 |
Wilms tumor 1 homolog |
78 |
0.91 |
chr7_101377838_101379825 | 19.39 |
Arap1 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 |
462 |
0.71 |
chr8_57320946_57324000 | 19.25 |
Hand2os1 |
Hand2, opposite strand 1 |
1245 |
0.3 |
chr1_130740681_130741391 | 19.21 |
Gm28857 |
predicted gene 28857 |
291 |
0.71 |
chr19_7294483_7295524 | 18.89 |
Mark2 |
MAP/microtubule affinity regulating kinase 2 |
444 |
0.7 |
chr8_33884869_33886307 | 18.84 |
Gm26978 |
predicted gene, 26978 |
159 |
0.95 |
chr5_107724563_107727169 | 18.81 |
Gfi1 |
growth factor independent 1 transcription repressor |
61 |
0.88 |
chr3_135608020_135608578 | 18.78 |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 |
29 |
0.98 |
chr4_115059803_115061295 | 18.78 |
Tal1 |
T cell acute lymphocytic leukemia 1 |
1041 |
0.47 |
chr17_48300015_48301474 | 18.29 |
Treml2 |
triggering receptor expressed on myeloid cells-like 2 |
358 |
0.8 |
chr8_121082801_121085531 | 18.19 |
Foxf1 |
forkhead box F1 |
220 |
0.71 |
chr15_5107710_5108629 | 18.17 |
Card6 |
caspase recruitment domain family, member 6 |
315 |
0.81 |
chr11_97439854_97442222 | 18.14 |
Arhgap23 |
Rho GTPase activating protein 23 |
4753 |
0.18 |
chr8_70765697_70766944 | 18.07 |
6330537M06Rik |
RIKEN cDNA 6330537M06 gene |
259 |
0.52 |
chr14_63244119_63245953 | 17.85 |
Gata4 |
GATA binding protein 4 |
212 |
0.93 |
chr6_99095299_99096526 | 17.54 |
Foxp1 |
forkhead box P1 |
293 |
0.93 |
chr2_25195300_25197035 | 17.42 |
Tor4a |
torsin family 4, member A |
592 |
0.43 |
chr17_36869615_36870619 | 17.18 |
Trim10 |
tripartite motif-containing 10 |
543 |
0.55 |
chr8_122546551_122549259 | 17.03 |
Piezo1 |
piezo-type mechanosensitive ion channel component 1 |
3424 |
0.12 |
chr14_75178051_75179727 | 17.02 |
Lcp1 |
lymphocyte cytosolic protein 1 |
2681 |
0.23 |
chr18_11049995_11051717 | 16.86 |
Gata6os |
GATA binding protein 6, opposite strand |
631 |
0.64 |
chr4_115057577_115059724 | 16.76 |
Tal1 |
T cell acute lymphocytic leukemia 1 |
839 |
0.56 |
chr12_111943340_111944555 | 16.70 |
5033406O09Rik |
RIKEN cDNA 5033406O09 gene |
199 |
0.89 |
chr18_38188855_38189945 | 16.69 |
Pcdh1 |
protocadherin 1 |
13763 |
0.13 |
chr15_99029361_99031026 | 16.51 |
Tuba1c |
tubulin, alpha 1C |
128 |
0.92 |
chr10_77112255_77113959 | 16.51 |
Col18a1 |
collagen, type XVIII, alpha 1 |
598 |
0.73 |
chr16_33751298_33751922 | 16.50 |
Heg1 |
heart development protein with EGF-like domains 1 |
1546 |
0.4 |
chr11_103102696_103105788 | 16.50 |
Acbd4 |
acyl-Coenzyme A binding domain containing 4 |
463 |
0.7 |
chr17_46460333_46461548 | 16.49 |
Gm47119 |
predicted gene, 47119 |
15567 |
0.09 |
chr19_10015065_10016667 | 16.29 |
Rab3il1 |
RAB3A interacting protein (rabin3)-like 1 |
822 |
0.48 |
chr17_85686512_85689764 | 16.21 |
Six2 |
sine oculis-related homeobox 2 |
116 |
0.96 |
chr8_84836764_84838739 | 16.05 |
Rad23a |
RAD23 homolog A, nucleotide excision repair protein |
296 |
0.75 |
chr2_24386288_24387076 | 16.04 |
Psd4 |
pleckstrin and Sec7 domain containing 4 |
65 |
0.97 |
chr18_35739288_35740804 | 15.93 |
Sting1 |
stimulator of interferon response cGAMP interactor 1 |
30 |
0.95 |
chr8_70493071_70496051 | 15.88 |
Crlf1 |
cytokine receptor-like factor 1 |
1200 |
0.25 |
chr2_148043571_148045987 | 15.87 |
Foxa2 |
forkhead box A2 |
685 |
0.65 |
chr16_38362450_38363226 | 15.84 |
Popdc2 |
popeye domain containing 2 |
593 |
0.63 |
chr8_23034845_23035677 | 15.68 |
Ank1 |
ankyrin 1, erythroid |
30 |
0.98 |
chr5_119673827_119675890 | 15.39 |
Tbx3 |
T-box 3 |
587 |
0.67 |
chr6_52224853_52226609 | 15.37 |
Hoxa9 |
homeobox A9 |
458 |
0.51 |
chr4_154926952_154928851 | 15.37 |
Tnfrsf14 |
tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) |
176 |
0.92 |
chr11_115899671_115901427 | 15.28 |
Smim5 |
small integral membrane protein 5 |
347 |
0.75 |
chr19_17355077_17356896 | 15.23 |
Gcnt1 |
glucosaminyl (N-acetyl) transferase 1, core 2 |
681 |
0.75 |
chr8_84701273_84703379 | 15.16 |
Lyl1 |
lymphoblastomic leukemia 1 |
545 |
0.59 |
chr1_87620304_87621692 | 15.09 |
Inpp5d |
inositol polyphosphate-5-phosphatase D |
371 |
0.85 |
chrX_143825863_143827628 | 15.05 |
Capn6 |
calpain 6 |
587 |
0.46 |
chr18_75384437_75388058 | 15.04 |
Smad7 |
SMAD family member 7 |
11333 |
0.21 |
chr4_62515406_62516411 | 15.00 |
Alad |
aminolevulinate, delta-, dehydratase |
3973 |
0.13 |
chr3_103736860_103738443 | 14.95 |
Olfml3 |
olfactomedin-like 3 |
317 |
0.76 |
chr1_161766766_161767491 | 14.90 |
Gm5049 |
predicted gene 5049 |
21072 |
0.12 |
chr3_95172192_95174377 | 14.86 |
Sema6c |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6C |
2479 |
0.12 |
chr18_14705973_14706778 | 14.84 |
Psma8 |
proteasome subunit alpha 8 |
172 |
0.95 |
chr11_75165245_75169157 | 14.83 |
Hic1 |
hypermethylated in cancer 1 |
945 |
0.35 |
chr4_140813807_140815024 | 14.82 |
Gm13032 |
predicted gene 13032 |
3422 |
0.16 |
chr2_168169487_168170640 | 14.82 |
Gm24561 |
predicted gene, 24561 |
8189 |
0.11 |
chr18_61952844_61953759 | 14.67 |
Sh3tc2 |
SH3 domain and tetratricopeptide repeats 2 |
217 |
0.94 |
chr11_70228540_70230880 | 14.57 |
Bcl6b |
B cell CLL/lymphoma 6, member B |
29 |
0.93 |
chr13_106835269_106836682 | 14.53 |
Lrrc70 |
leucine rich repeat containing 70 |
173 |
0.7 |
chr5_118482858_118484042 | 14.44 |
Gm15754 |
predicted gene 15754 |
3517 |
0.25 |
chr19_5842574_5845856 | 14.39 |
Neat1 |
nuclear paraspeckle assembly transcript 1 (non-protein coding) |
1044 |
0.25 |
chr11_85836730_85838643 | 14.33 |
Tbx2 |
T-box 2 |
5135 |
0.14 |
chr7_16844794_16846016 | 14.28 |
Prkd2 |
protein kinase D2 |
172 |
0.9 |
chr11_72960644_72962160 | 14.26 |
Atp2a3 |
ATPase, Ca++ transporting, ubiquitous |
112 |
0.95 |
chr7_31040855_31042728 | 14.25 |
Fxyd5 |
FXYD domain-containing ion transport regulator 5 |
48 |
0.93 |
chr7_83654607_83655449 | 14.24 |
Il16 |
interleukin 16 |
297 |
0.84 |
chr8_88300415_88300996 | 14.17 |
Adcy7 |
adenylate cyclase 7 |
326 |
0.89 |
chr12_117657998_117660727 | 14.16 |
Rapgef5 |
Rap guanine nucleotide exchange factor (GEF) 5 |
1328 |
0.51 |
chr5_147304305_147307985 | 14.09 |
Cdx2 |
caudal type homeobox 2 |
1125 |
0.33 |
chr2_36230119_36231737 | 14.08 |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
372 |
0.79 |
chr4_46854379_46855929 | 14.01 |
Gabbr2 |
gamma-aminobutyric acid (GABA) B receptor, 2 |
4748 |
0.3 |
chr6_31125380_31126701 | 14.00 |
5330406M23Rik |
RIKEN cDNA 5330406M23 gene |
15120 |
0.11 |
chr5_119672433_119673011 | 13.93 |
Tbx3os1 |
T-box 3, opposite strand 1 |
1357 |
0.31 |
chr10_7472799_7473709 | 13.91 |
Ulbp1 |
UL16 binding protein 1 |
87 |
0.97 |
chr8_57326741_57329467 | 13.90 |
Hand2os1 |
Hand2, opposite strand 1 |
3871 |
0.15 |
chr15_76666348_76670076 | 13.88 |
Foxh1 |
forkhead box H1 |
1590 |
0.15 |
chr2_103958009_103958847 | 13.83 |
Lmo2 |
LIM domain only 2 |
433 |
0.78 |
chr7_44350602_44354420 | 13.81 |
Shank1 |
SH3 and multiple ankyrin repeat domains 1 |
1749 |
0.15 |
chr2_127374543_127375463 | 13.73 |
Adra2b |
adrenergic receptor, alpha 2b |
11717 |
0.14 |
chr8_94976904_94978618 | 13.71 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
652 |
0.59 |
chr2_35460488_35462662 | 13.70 |
Ggta1 |
glycoprotein galactosyltransferase alpha 1, 3 |
126 |
0.94 |
chr1_172501767_172503923 | 13.62 |
Tagln2 |
transgelin 2 |
1593 |
0.22 |
chr11_116076531_116078496 | 13.61 |
Unc13d |
unc-13 homolog D |
77 |
0.94 |
chr10_76905878_76906696 | 13.60 |
Pcbp3 |
poly(rC) binding protein 3 |
425 |
0.86 |
chr6_5255342_5256653 | 13.59 |
Pon3 |
paraoxonase 3 |
217 |
0.93 |
chr6_127581934_127583022 | 13.55 |
Cracr2a |
calcium release activated channel regulator 2A |
4503 |
0.24 |
chr1_51288641_51290950 | 13.51 |
Cavin2 |
caveolae associated 2 |
669 |
0.72 |
chr1_165717936_165719081 | 13.49 |
Gm37073 |
predicted gene, 37073 |
3048 |
0.14 |
chr18_10532272_10533276 | 13.36 |
Gm24894 |
predicted gene, 24894 |
18632 |
0.16 |
chr9_21181264_21182159 | 13.34 |
Pde4a |
phosphodiesterase 4A, cAMP specific |
95 |
0.94 |
chr11_98581976_98582749 | 13.33 |
Ormdl3 |
ORM1-like 3 (S. cerevisiae) |
5006 |
0.11 |
chr2_165954735_165955231 | 13.21 |
Gm11462 |
predicted gene 11462 |
4806 |
0.15 |
chr2_62440740_62441565 | 13.21 |
Gm13565 |
predicted gene 13565 |
10 |
0.97 |
chr2_84936571_84938205 | 13.16 |
Slc43a3 |
solute carrier family 43, member 3 |
498 |
0.71 |
chr12_85686314_85687645 | 13.14 |
Batf |
basic leucine zipper transcription factor, ATF-like |
310 |
0.85 |
chr3_14889110_14890285 | 13.06 |
Car2 |
carbonic anhydrase 2 |
3058 |
0.25 |
chr10_62664723_62665865 | 13.02 |
Gm18514 |
predicted gene, 18514 |
4509 |
0.13 |
chr14_52140471_52142121 | 13.01 |
Rpgrip1 |
retinitis pigmentosa GTPase regulator interacting protein 1 |
4068 |
0.13 |
chr11_109587022_109588156 | 12.98 |
Wipi1 |
WD repeat domain, phosphoinositide interacting 1 |
23843 |
0.13 |
chr10_97566192_97567945 | 12.97 |
Lum |
lumican |
1940 |
0.32 |
chr7_31115037_31115979 | 12.97 |
Hpn |
hepsin |
218 |
0.86 |
chr12_32208046_32209200 | 12.96 |
Pik3cg |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma |
12 |
0.98 |
chr2_84423814_84425562 | 12.86 |
Calcrl |
calcitonin receptor-like |
578 |
0.75 |
chr3_138130180_138131364 | 12.82 |
Mttp |
microsomal triglyceride transfer protein |
605 |
0.65 |
chr5_137596535_137597450 | 12.79 |
Mospd3 |
motile sperm domain containing 3 |
3699 |
0.08 |
chr15_103252820_103253410 | 12.77 |
Nfe2 |
nuclear factor, erythroid derived 2 |
37 |
0.95 |
chr2_9882196_9886301 | 12.73 |
9230102O04Rik |
RIKEN cDNA 9230102O04 gene |
255 |
0.84 |
chr15_76197527_76199931 | 12.71 |
Plec |
plectin |
520 |
0.59 |
chr6_51177550_51178505 | 12.70 |
Mir148a |
microRNA 148a |
91883 |
0.08 |
chr9_21152788_21154079 | 12.68 |
Cdc37 |
cell division cycle 37 |
3451 |
0.12 |
chr7_142662290_142664788 | 12.65 |
Igf2os |
insulin-like growth factor 2, opposite strand |
1599 |
0.21 |
chr17_34589250_34590501 | 12.64 |
Gpsm3 |
G-protein signalling modulator 3 (AGS3-like, C. elegans) |
69 |
0.89 |
chr17_86300838_86301701 | 12.62 |
2010106C02Rik |
RIKEN cDNA 2010106C02 gene |
14091 |
0.27 |
chr19_34253411_34255499 | 12.60 |
Acta2 |
actin, alpha 2, smooth muscle, aorta |
225 |
0.92 |
chr9_114562610_114564528 | 12.59 |
Trim71 |
tripartite motif-containing 71 |
800 |
0.6 |
chr11_117779316_117780928 | 12.57 |
Tmc6 |
transmembrane channel-like gene family 6 |
472 |
0.61 |
chr9_44340460_44342952 | 12.56 |
Hmbs |
hydroxymethylbilane synthase |
473 |
0.51 |
chr11_97511052_97512791 | 12.52 |
Gm11611 |
predicted gene 11611 |
9974 |
0.12 |
chr10_59403301_59404650 | 12.50 |
Pla2g12b |
phospholipase A2, group XIIB |
315 |
0.88 |
chr15_97361270_97362062 | 12.49 |
Pced1b |
PC-esterase domain containing 1B |
449 |
0.88 |
chr4_138972366_138973618 | 12.48 |
Tmco4 |
transmembrane and coiled-coil domains 4 |
83 |
0.96 |
chr8_123978308_123979538 | 12.47 |
Abcb10 |
ATP-binding cassette, sub-family B (MDR/TAP), member 10 |
4199 |
0.12 |
chr6_83032569_83034015 | 12.44 |
Dok1 |
docking protein 1 |
176 |
0.8 |
chr7_19180970_19181875 | 12.41 |
Mir330 |
microRNA 330 |
43 |
0.54 |
chr14_27237814_27239092 | 12.41 |
Gm49616 |
predicted gene, 49616 |
391 |
0.49 |
chr8_57331786_57332929 | 12.36 |
5033428I22Rik |
RIKEN cDNA 5033428I22 gene |
78 |
0.95 |
chr10_117952049_117952571 | 12.34 |
4933411E08Rik |
RIKEN cDNA 4933411E08 gene |
26851 |
0.15 |
chr5_121833321_121834947 | 12.33 |
1700008B11Rik |
RIKEN cDNA 1700008B11 gene |
1061 |
0.33 |
chr10_81497570_81499812 | 12.29 |
S1pr4 |
sphingosine-1-phosphate receptor 4 |
1441 |
0.16 |
chr4_44711553_44714511 | 12.27 |
Pax5 |
paired box 5 |
2545 |
0.22 |
chr12_73052052_73054521 | 12.24 |
Six1 |
sine oculis-related homeobox 1 |
601 |
0.76 |
chr16_32200297_32201417 | 12.16 |
Bex6 |
brain expressed family member 6 |
14671 |
0.11 |
chr19_5660333_5662014 | 12.12 |
Sipa1 |
signal-induced proliferation associated gene 1 |
462 |
0.59 |
chr11_77783639_77784980 | 12.09 |
Gm10277 |
predicted gene 10277 |
3438 |
0.18 |
chrX_137118132_137120673 | 12.03 |
Esx1 |
extraembryonic, spermatogenesis, homeobox 1 |
769 |
0.36 |
chr5_76856634_76858112 | 11.96 |
C530008M17Rik |
RIKEN cDNA C530008M17 gene |
1469 |
0.39 |
chr11_117781898_117782456 | 11.93 |
Tmc6 |
transmembrane channel-like gene family 6 |
21 |
0.57 |
chr8_70609276_70610571 | 11.89 |
Gm45546 |
predicted gene 45546 |
502 |
0.53 |
chr9_105520039_105521535 | 11.81 |
Atp2c1 |
ATPase, Ca++-sequestering |
360 |
0.86 |
chr1_120269879_120270612 | 11.77 |
Steap3 |
STEAP family member 3 |
178 |
0.96 |
chr7_80386817_80388333 | 11.74 |
Fes |
feline sarcoma oncogene |
156 |
0.91 |
chr2_32646588_32647989 | 11.72 |
Eng |
endoglin |
295 |
0.76 |
chr16_32129573_32130603 | 11.70 |
Nrros |
negative regulator of reactive oxygen species |
17793 |
0.1 |
chr2_127369985_127371247 | 11.67 |
Adra2b |
adrenergic receptor, alpha 2b |
7330 |
0.15 |
chr8_119437065_119437967 | 11.66 |
Osgin1 |
oxidative stress induced growth inhibitor 1 |
327 |
0.86 |
chr3_89136417_89137539 | 11.64 |
Pklr |
pyruvate kinase liver and red blood cell |
355 |
0.69 |
chr2_32081622_32082932 | 11.61 |
Fam78a |
family with sequence similarity 78, member A |
1506 |
0.26 |
chr7_127090806_127091953 | 11.55 |
AI467606 |
expressed sequence AI467606 |
20 |
0.93 |
chr2_68782317_68783265 | 11.55 |
Gm13612 |
predicted gene 13612 |
48226 |
0.11 |
chr2_73484519_73485212 | 11.53 |
Wipf1 |
WAS/WASL interacting protein family, member 1 |
898 |
0.55 |
chr14_77904388_77905097 | 11.51 |
Epsti1 |
epithelial stromal interaction 1 (breast) |
335 |
0.9 |
chr7_16783072_16783914 | 11.45 |
Slc1a5 |
solute carrier family 1 (neutral amino acid transporter), member 5 |
1095 |
0.36 |
chr7_133114831_133116529 | 11.42 |
Ctbp2 |
C-terminal binding protein 2 |
2981 |
0.2 |
chr6_136857054_136858156 | 11.40 |
Art4 |
ADP-ribosyltransferase 4 |
128 |
0.92 |
chr17_85485071_85487191 | 11.39 |
Rpl31-ps16 |
ribosomal protein L31, pseudogene 16 |
12502 |
0.23 |
chr4_63402318_63403749 | 11.38 |
Akna |
AT-hook transcription factor |
321 |
0.84 |
chr2_35691764_35692937 | 11.32 |
Dab2ip |
disabled 2 interacting protein |
17 |
0.98 |
chr5_90492212_90493160 | 11.32 |
Afp |
alpha fetoprotein |
1448 |
0.33 |
chr1_181852456_181853806 | 11.31 |
Gm5533 |
predicted gene 5533 |
58 |
0.96 |
chr3_89419740_89420197 | 11.30 |
Shc1 |
src homology 2 domain-containing transforming protein C1 |
665 |
0.41 |
chr2_166553318_166553874 | 11.30 |
Prex1 |
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1 |
19381 |
0.19 |
chr17_78881749_78883023 | 11.29 |
Eif2ak2 |
eukaryotic translation initiation factor 2-alpha kinase 2 |
162 |
0.92 |
chr7_133700764_133701966 | 11.28 |
Uros |
uroporphyrinogen III synthase |
1173 |
0.35 |
chr5_53469318_53470522 | 11.28 |
Rbpj |
recombination signal binding protein for immunoglobulin kappa J region |
3768 |
0.25 |
chr7_81057643_81058977 | 11.22 |
Alpk3 |
alpha-kinase 3 |
710 |
0.41 |
chr9_21846522_21847452 | 11.19 |
Dock6 |
dedicator of cytokinesis 6 |
5629 |
0.11 |
chr7_142658126_142659753 | 11.16 |
Igf2 |
insulin-like growth factor 2 |
550 |
0.47 |
chr5_24590942_24592511 | 11.15 |
Mir671 |
microRNA 671 |
388 |
0.69 |
chr12_21777930_21779205 | 11.15 |
Mrto4-ps2 |
mRNA turnover 4, pseudogene 2 |
1860 |
0.48 |
chr8_27106426_27107774 | 11.13 |
Adgra2 |
adhesion G protein-coupled receptor A2 |
7033 |
0.12 |
chr9_69454872_69455904 | 11.08 |
Anxa2 |
annexin A2 |
1322 |
0.26 |
chr7_99594627_99596228 | 11.05 |
Arrb1 |
arrestin, beta 1 |
804 |
0.48 |
chr7_128301638_128302100 | 11.05 |
BC017158 |
cDNA sequence BC017158 |
3699 |
0.12 |
chr19_5691875_5693863 | 11.04 |
Map3k11 |
mitogen-activated protein kinase kinase kinase 11 |
26 |
0.92 |
chr10_62327314_62328305 | 11.03 |
Hk1 |
hexokinase 1 |
42 |
0.97 |
chr3_36853598_36854537 | 11.03 |
4932438A13Rik |
RIKEN cDNA 4932438A13 gene |
9037 |
0.21 |
chr6_136940269_136941762 | 11.03 |
Arhgdib |
Rho, GDP dissociation inhibitor (GDI) beta |
488 |
0.73 |
chr13_111867705_111868762 | 10.93 |
Gm15326 |
predicted gene 15326 |
297 |
0.86 |
chr9_40323395_40324376 | 10.92 |
1700110K17Rik |
RIKEN cDNA 1700110K17 gene |
459 |
0.71 |
chr18_11051784_11053949 | 10.88 |
Gata6 |
GATA binding protein 6 |
178 |
0.66 |
chr10_128149134_128150006 | 10.88 |
Rbms2 |
RNA binding motif, single stranded interacting protein 2 |
5841 |
0.1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
17.5 | 52.5 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
16.1 | 48.4 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
14.6 | 43.8 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
13.9 | 41.7 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
11.2 | 33.5 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
11.0 | 33.1 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
9.7 | 29.2 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
9.4 | 28.1 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
8.8 | 43.8 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
8.7 | 8.7 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
8.5 | 8.5 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
8.5 | 25.4 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
8.3 | 24.9 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
8.1 | 24.2 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
8.0 | 24.0 | GO:0003166 | bundle of His development(GO:0003166) |
7.9 | 31.5 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
7.6 | 30.4 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
7.3 | 22.0 | GO:0048769 | sarcomerogenesis(GO:0048769) |
7.2 | 7.2 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
7.2 | 28.9 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
6.8 | 33.9 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
6.7 | 33.6 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
6.7 | 26.7 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
6.6 | 19.9 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
6.6 | 19.8 | GO:0061010 | gall bladder development(GO:0061010) |
6.5 | 19.5 | GO:0036394 | amylase secretion(GO:0036394) |
6.5 | 19.5 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
6.5 | 26.0 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
6.5 | 19.5 | GO:0007525 | somatic muscle development(GO:0007525) |
6.5 | 32.4 | GO:0003180 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
6.4 | 25.8 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
6.4 | 19.3 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
6.3 | 18.9 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
6.3 | 25.1 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
6.2 | 18.7 | GO:0048370 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
6.1 | 18.2 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
6.0 | 18.1 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
6.0 | 6.0 | GO:0070627 | ferrous iron import(GO:0070627) |
6.0 | 12.0 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
6.0 | 11.9 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
6.0 | 17.9 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
5.9 | 17.8 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
5.9 | 29.7 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
5.8 | 28.9 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
5.7 | 28.6 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
5.7 | 17.1 | GO:0002432 | granuloma formation(GO:0002432) |
5.6 | 16.8 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
5.5 | 11.0 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
5.5 | 21.9 | GO:0097461 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
5.4 | 21.5 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
5.3 | 10.5 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
5.2 | 26.0 | GO:0071918 | urea transmembrane transport(GO:0071918) |
5.2 | 10.4 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
5.2 | 15.5 | GO:0050904 | diapedesis(GO:0050904) |
5.1 | 15.4 | GO:0072277 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
5.1 | 15.2 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
5.1 | 101.5 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
5.1 | 10.1 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
4.9 | 14.7 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
4.8 | 14.3 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
4.7 | 14.0 | GO:0033668 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
4.7 | 14.0 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
4.6 | 18.6 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
4.6 | 13.8 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
4.6 | 4.6 | GO:0035995 | detection of muscle stretch(GO:0035995) |
4.6 | 27.4 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
4.6 | 18.2 | GO:0006742 | NADP catabolic process(GO:0006742) |
4.6 | 9.1 | GO:0042908 | xenobiotic transport(GO:0042908) |
4.6 | 9.1 | GO:0032672 | regulation of interleukin-3 production(GO:0032672) |
4.5 | 18.0 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
4.5 | 13.5 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
4.5 | 8.9 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
4.5 | 4.5 | GO:0007403 | glial cell fate determination(GO:0007403) |
4.4 | 17.7 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
4.4 | 8.8 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
4.3 | 17.4 | GO:0070836 | caveola assembly(GO:0070836) |
4.3 | 8.7 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
4.3 | 13.0 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
4.3 | 4.3 | GO:1901203 | positive regulation of extracellular matrix assembly(GO:1901203) regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
4.3 | 4.3 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
4.2 | 29.6 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
4.2 | 12.6 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
4.2 | 16.7 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
4.2 | 4.2 | GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
4.1 | 12.4 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
4.1 | 20.7 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
4.1 | 12.4 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
4.1 | 8.2 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
4.1 | 20.5 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
4.1 | 20.4 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
4.1 | 8.2 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
4.1 | 12.2 | GO:1902966 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
4.0 | 32.1 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
4.0 | 16.0 | GO:0032264 | IMP salvage(GO:0032264) |
4.0 | 23.9 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
4.0 | 12.0 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
4.0 | 11.9 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
4.0 | 31.6 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
3.9 | 11.8 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
3.9 | 15.8 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
3.9 | 7.9 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
3.9 | 7.9 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
3.9 | 7.8 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
3.9 | 11.7 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
3.9 | 15.5 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
3.9 | 7.7 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
3.9 | 3.9 | GO:0097048 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
3.8 | 15.3 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
3.8 | 3.8 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
3.8 | 15.2 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
3.8 | 3.8 | GO:0061325 | cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
3.8 | 11.4 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
3.8 | 11.3 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
3.8 | 3.8 | GO:0015793 | glycerol transport(GO:0015793) |
3.8 | 11.3 | GO:0046208 | spermine catabolic process(GO:0046208) |
3.7 | 33.7 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
3.7 | 25.9 | GO:2000392 | regulation of lamellipodium morphogenesis(GO:2000392) |
3.7 | 14.8 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
3.7 | 7.4 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
3.7 | 29.5 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
3.7 | 22.1 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
3.7 | 18.3 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
3.6 | 10.9 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
3.6 | 18.1 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
3.6 | 7.2 | GO:0046104 | thymidine metabolic process(GO:0046104) |
3.6 | 21.6 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
3.6 | 10.8 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
3.6 | 10.8 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
3.6 | 17.9 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
3.6 | 10.7 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
3.6 | 7.1 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
3.5 | 31.9 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
3.5 | 3.5 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
3.5 | 14.1 | GO:0061687 | detoxification of copper ion(GO:0010273) detoxification of inorganic compound(GO:0061687) stress response to copper ion(GO:1990169) |
3.5 | 7.0 | GO:0007494 | midgut development(GO:0007494) |
3.5 | 24.4 | GO:0032782 | bile acid secretion(GO:0032782) |
3.5 | 10.4 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
3.5 | 10.4 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
3.5 | 13.8 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
3.4 | 6.9 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
3.4 | 10.3 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
3.4 | 10.3 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
3.4 | 6.8 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
3.4 | 17.0 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
3.4 | 20.3 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
3.4 | 23.7 | GO:0015825 | L-serine transport(GO:0015825) |
3.4 | 6.7 | GO:0045764 | positive regulation of cellular amino acid metabolic process(GO:0045764) |
3.4 | 3.4 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
3.3 | 13.3 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
3.3 | 6.6 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
3.3 | 13.3 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
3.3 | 10.0 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
3.3 | 13.2 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
3.3 | 9.9 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
3.3 | 9.9 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
3.3 | 3.3 | GO:0060956 | endocardial cell differentiation(GO:0060956) |
3.3 | 13.0 | GO:0010424 | DNA methylation on cytosine within a CG sequence(GO:0010424) DNA methylation on cytosine(GO:0032776) |
3.3 | 13.0 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
3.2 | 19.5 | GO:0090527 | actin filament reorganization(GO:0090527) |
3.2 | 38.9 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
3.2 | 3.2 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
3.2 | 9.6 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
3.2 | 6.4 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
3.2 | 19.1 | GO:0001866 | NK T cell proliferation(GO:0001866) |
3.2 | 6.3 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
3.2 | 9.5 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
3.2 | 6.3 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
3.2 | 3.2 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
3.2 | 28.4 | GO:0070269 | pyroptosis(GO:0070269) |
3.1 | 28.3 | GO:0043249 | erythrocyte maturation(GO:0043249) |
3.1 | 12.6 | GO:0097286 | iron ion import(GO:0097286) |
3.1 | 9.4 | GO:0008228 | opsonization(GO:0008228) |
3.1 | 3.1 | GO:1903012 | positive regulation of bone development(GO:1903012) |
3.1 | 25.1 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
3.1 | 9.4 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
3.1 | 9.4 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
3.1 | 24.9 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
3.1 | 24.9 | GO:0033194 | response to hydroperoxide(GO:0033194) |
3.1 | 6.2 | GO:0003163 | sinoatrial node development(GO:0003163) |
3.1 | 21.7 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
3.1 | 9.3 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
3.1 | 3.1 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
3.1 | 3.1 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
3.1 | 9.2 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
3.1 | 6.1 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
3.0 | 9.1 | GO:0032345 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
3.0 | 3.0 | GO:0010159 | specification of organ position(GO:0010159) |
3.0 | 3.0 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
2.9 | 8.8 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
2.9 | 8.8 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
2.9 | 11.8 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
2.9 | 5.9 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
2.9 | 17.5 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
2.9 | 11.5 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
2.9 | 8.6 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
2.9 | 2.9 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
2.9 | 2.9 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
2.9 | 11.4 | GO:0036302 | atrioventricular canal development(GO:0036302) |
2.9 | 11.4 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
2.9 | 25.7 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
2.9 | 8.6 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
2.8 | 8.5 | GO:0002159 | desmosome assembly(GO:0002159) |
2.8 | 8.5 | GO:0018992 | germ-line sex determination(GO:0018992) |
2.8 | 2.8 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
2.8 | 2.8 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
2.8 | 17.0 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
2.8 | 5.6 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
2.8 | 5.6 | GO:0002930 | trabecular meshwork development(GO:0002930) |
2.8 | 8.4 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
2.8 | 16.7 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
2.8 | 11.1 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
2.8 | 13.9 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
2.8 | 2.8 | GO:1901656 | glycoside transport(GO:1901656) |
2.8 | 13.9 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
2.8 | 5.5 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
2.8 | 2.8 | GO:0002468 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) |
2.8 | 8.3 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
2.8 | 2.8 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
2.8 | 11.0 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
2.7 | 2.7 | GO:1901671 | positive regulation of superoxide dismutase activity(GO:1901671) positive regulation of removal of superoxide radicals(GO:1904833) |
2.7 | 8.2 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
2.7 | 8.2 | GO:1900221 | regulation of beta-amyloid clearance(GO:1900221) |
2.7 | 8.2 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
2.7 | 43.3 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
2.7 | 5.4 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
2.7 | 10.8 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
2.7 | 16.0 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
2.7 | 8.0 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
2.6 | 2.6 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
2.6 | 2.6 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
2.6 | 7.8 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
2.6 | 10.4 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
2.6 | 5.2 | GO:0031034 | myosin filament assembly(GO:0031034) |
2.6 | 2.6 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
2.6 | 5.2 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
2.6 | 41.4 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
2.6 | 12.9 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
2.6 | 7.7 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
2.6 | 2.6 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
2.6 | 2.6 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
2.6 | 10.2 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
2.5 | 5.1 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
2.5 | 10.2 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) |
2.5 | 2.5 | GO:0070384 | Harderian gland development(GO:0070384) |
2.5 | 28.0 | GO:0006855 | drug transmembrane transport(GO:0006855) |
2.5 | 10.2 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
2.5 | 2.5 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
2.5 | 2.5 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
2.5 | 7.6 | GO:0006901 | vesicle coating(GO:0006901) vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
2.5 | 5.0 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
2.5 | 12.5 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
2.5 | 15.0 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
2.5 | 5.0 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
2.5 | 10.0 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
2.5 | 7.5 | GO:0035483 | gastric emptying(GO:0035483) |
2.5 | 5.0 | GO:0035754 | B cell chemotaxis(GO:0035754) |
2.5 | 19.8 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
2.5 | 2.5 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
2.5 | 9.9 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
2.5 | 14.7 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
2.4 | 2.4 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
2.4 | 17.1 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
2.4 | 9.8 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
2.4 | 12.1 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
2.4 | 2.4 | GO:0060058 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
2.4 | 2.4 | GO:0060435 | bronchiole development(GO:0060435) |
2.4 | 7.3 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
2.4 | 9.7 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
2.4 | 2.4 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
2.4 | 12.1 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
2.4 | 16.9 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
2.4 | 4.8 | GO:0031033 | myosin filament organization(GO:0031033) |
2.4 | 7.2 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
2.4 | 9.5 | GO:0018214 | protein carboxylation(GO:0018214) |
2.4 | 2.4 | GO:0070673 | response to interleukin-18(GO:0070673) |
2.4 | 9.5 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
2.4 | 2.4 | GO:0034442 | regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) |
2.4 | 2.4 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
2.4 | 9.5 | GO:0002317 | plasma cell differentiation(GO:0002317) |
2.4 | 7.1 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
2.4 | 9.5 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
2.4 | 2.4 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
2.4 | 7.1 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
2.4 | 2.4 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
2.4 | 4.7 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
2.3 | 4.7 | GO:1904238 | pericyte cell differentiation(GO:1904238) |
2.3 | 14.0 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
2.3 | 7.0 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
2.3 | 7.0 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
2.3 | 23.3 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
2.3 | 4.6 | GO:0043173 | nucleotide salvage(GO:0043173) |
2.3 | 9.3 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
2.3 | 4.6 | GO:0006113 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
2.3 | 25.5 | GO:1903392 | negative regulation of adherens junction organization(GO:1903392) |
2.3 | 6.9 | GO:0044004 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
2.3 | 6.9 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
2.3 | 2.3 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
2.3 | 11.5 | GO:0018101 | protein citrullination(GO:0018101) |
2.3 | 2.3 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
2.3 | 2.3 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
2.3 | 2.3 | GO:0048625 | myoblast fate commitment(GO:0048625) |
2.3 | 9.1 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
2.3 | 16.0 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
2.3 | 22.8 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
2.3 | 9.1 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
2.3 | 2.3 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
2.3 | 6.8 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
2.3 | 6.8 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
2.2 | 11.2 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
2.2 | 2.2 | GO:0065001 | specification of axis polarity(GO:0065001) |
2.2 | 2.2 | GO:0031944 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
2.2 | 9.0 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
2.2 | 2.2 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
2.2 | 4.5 | GO:0001810 | regulation of type I hypersensitivity(GO:0001810) positive regulation of type I hypersensitivity(GO:0001812) type I hypersensitivity(GO:0016068) |
2.2 | 6.7 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
2.2 | 15.5 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
2.2 | 28.7 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
2.2 | 13.2 | GO:0035404 | histone-serine phosphorylation(GO:0035404) |
2.2 | 13.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
2.2 | 11.0 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
2.2 | 4.4 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
2.2 | 4.4 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
2.2 | 24.0 | GO:0035855 | megakaryocyte development(GO:0035855) |
2.2 | 39.3 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
2.2 | 4.4 | GO:0042117 | monocyte activation(GO:0042117) |
2.2 | 8.7 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
2.2 | 10.9 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
2.2 | 8.7 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
2.2 | 8.6 | GO:0072675 | osteoclast fusion(GO:0072675) |
2.2 | 6.5 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
2.1 | 17.2 | GO:0071361 | cellular response to ethanol(GO:0071361) |
2.1 | 17.1 | GO:0016540 | protein autoprocessing(GO:0016540) |
2.1 | 6.4 | GO:1903140 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
2.1 | 6.4 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
2.1 | 4.3 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
2.1 | 8.5 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
2.1 | 19.1 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
2.1 | 10.6 | GO:0030953 | astral microtubule organization(GO:0030953) |
2.1 | 10.5 | GO:1904970 | brush border assembly(GO:1904970) |
2.1 | 16.7 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
2.1 | 2.1 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
2.1 | 2.1 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
2.1 | 6.2 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
2.1 | 10.4 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
2.1 | 16.6 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
2.1 | 6.2 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
2.1 | 6.2 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
2.1 | 10.3 | GO:2000726 | negative regulation of cardiac muscle cell differentiation(GO:2000726) |
2.1 | 14.4 | GO:0071295 | cellular response to vitamin(GO:0071295) |
2.1 | 10.3 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
2.1 | 2.1 | GO:0070572 | positive regulation of neuron projection regeneration(GO:0070572) |
2.0 | 14.3 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
2.0 | 2.0 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
2.0 | 8.2 | GO:0010587 | miRNA catabolic process(GO:0010587) |
2.0 | 10.2 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
2.0 | 6.1 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
2.0 | 28.4 | GO:0034340 | response to type I interferon(GO:0034340) |
2.0 | 4.1 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
2.0 | 6.1 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
2.0 | 4.0 | GO:0060347 | heart trabecula formation(GO:0060347) |
2.0 | 2.0 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
2.0 | 2.0 | GO:0072566 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
2.0 | 12.1 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
2.0 | 8.0 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
2.0 | 24.0 | GO:0007035 | vacuolar acidification(GO:0007035) |
2.0 | 8.0 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
2.0 | 2.0 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
2.0 | 7.9 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
2.0 | 9.9 | GO:0032494 | response to peptidoglycan(GO:0032494) |
2.0 | 2.0 | GO:0006415 | translational termination(GO:0006415) |
2.0 | 2.0 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
2.0 | 5.9 | GO:0070488 | neutrophil aggregation(GO:0070488) |
2.0 | 21.5 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
2.0 | 3.9 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
1.9 | 7.8 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
1.9 | 3.9 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) |
1.9 | 1.9 | GO:0034391 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
1.9 | 1.9 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
1.9 | 3.9 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
1.9 | 7.7 | GO:0044351 | macropinocytosis(GO:0044351) |
1.9 | 5.8 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
1.9 | 7.7 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
1.9 | 17.3 | GO:0031269 | pseudopodium assembly(GO:0031269) |
1.9 | 3.8 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
1.9 | 1.9 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
1.9 | 11.5 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
1.9 | 5.7 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
1.9 | 15.3 | GO:0032060 | bleb assembly(GO:0032060) |
1.9 | 11.4 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
1.9 | 7.6 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
1.9 | 43.7 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
1.9 | 3.8 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
1.9 | 13.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
1.9 | 9.4 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
1.9 | 5.6 | GO:0060056 | mammary gland involution(GO:0060056) |
1.9 | 9.4 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
1.9 | 16.9 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
1.9 | 3.7 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
1.9 | 5.6 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
1.9 | 1.9 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
1.9 | 14.9 | GO:0010226 | response to lithium ion(GO:0010226) |
1.9 | 9.3 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
1.9 | 1.9 | GO:0042119 | neutrophil activation involved in immune response(GO:0002283) neutrophil mediated immunity(GO:0002446) neutrophil activation(GO:0042119) neutrophil degranulation(GO:0043312) regulation of neutrophil activation(GO:1902563) |
1.9 | 20.4 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
1.8 | 24.0 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
1.8 | 9.2 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
1.8 | 3.7 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
1.8 | 14.7 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
1.8 | 22.0 | GO:0051601 | exocyst localization(GO:0051601) |
1.8 | 7.3 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
1.8 | 5.5 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
1.8 | 10.9 | GO:0001842 | neural fold formation(GO:0001842) |
1.8 | 9.1 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
1.8 | 14.6 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
1.8 | 7.3 | GO:0042045 | epithelial fluid transport(GO:0042045) |
1.8 | 5.4 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
1.8 | 1.8 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
1.8 | 9.1 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
1.8 | 7.2 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
1.8 | 3.6 | GO:0015669 | gas transport(GO:0015669) |
1.8 | 1.8 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
1.8 | 1.8 | GO:0014894 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
1.8 | 9.0 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.8 | 3.6 | GO:0060525 | prostate glandular acinus development(GO:0060525) |
1.8 | 21.6 | GO:0048535 | lymph node development(GO:0048535) |
1.8 | 9.0 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
1.8 | 9.0 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
1.8 | 5.4 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
1.8 | 1.8 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
1.8 | 1.8 | GO:0015886 | heme transport(GO:0015886) |
1.8 | 3.6 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
1.8 | 1.8 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
1.8 | 5.4 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
1.8 | 5.4 | GO:0006562 | proline catabolic process(GO:0006562) |
1.8 | 12.5 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
1.8 | 3.6 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
1.8 | 3.6 | GO:0010878 | cholesterol storage(GO:0010878) |
1.8 | 10.7 | GO:0071318 | cellular response to ATP(GO:0071318) |
1.8 | 10.6 | GO:0006477 | protein sulfation(GO:0006477) |
1.8 | 3.5 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
1.8 | 10.6 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
1.8 | 12.3 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
1.8 | 7.1 | GO:0039535 | regulation of RIG-I signaling pathway(GO:0039535) |
1.8 | 3.5 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
1.8 | 5.3 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
1.8 | 17.6 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
1.8 | 1.8 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
1.7 | 7.0 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
1.7 | 3.5 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
1.7 | 1.7 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
1.7 | 13.9 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
1.7 | 6.9 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
1.7 | 1.7 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
1.7 | 1.7 | GO:0010916 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
1.7 | 3.4 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
1.7 | 6.8 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
1.7 | 3.4 | GO:0032439 | endosome localization(GO:0032439) |
1.7 | 3.4 | GO:0046112 | nucleobase biosynthetic process(GO:0046112) |
1.7 | 5.1 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
1.7 | 8.5 | GO:0001955 | blood vessel maturation(GO:0001955) |
1.7 | 6.8 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
1.7 | 10.2 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
1.7 | 5.0 | GO:0009299 | mRNA transcription(GO:0009299) |
1.7 | 1.7 | GO:1904690 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
1.7 | 1.7 | GO:0048382 | mesendoderm development(GO:0048382) |
1.7 | 1.7 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
1.7 | 6.7 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
1.7 | 1.7 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
1.7 | 6.6 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
1.7 | 8.3 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
1.7 | 1.7 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
1.6 | 9.9 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
1.6 | 1.6 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
1.6 | 1.6 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
1.6 | 13.2 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
1.6 | 4.9 | GO:0006553 | lysine metabolic process(GO:0006553) |
1.6 | 4.9 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
1.6 | 1.6 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
1.6 | 4.9 | GO:0061511 | centriole elongation(GO:0061511) |
1.6 | 1.6 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
1.6 | 4.9 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
1.6 | 4.9 | GO:0000212 | meiotic spindle organization(GO:0000212) |
1.6 | 19.4 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
1.6 | 1.6 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
1.6 | 4.8 | GO:0018343 | protein farnesylation(GO:0018343) |
1.6 | 4.8 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
1.6 | 8.0 | GO:2000482 | regulation of interleukin-8 secretion(GO:2000482) |
1.6 | 4.8 | GO:0051451 | myoblast migration(GO:0051451) |
1.6 | 9.5 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
1.6 | 1.6 | GO:0006007 | glucose catabolic process(GO:0006007) |
1.6 | 14.2 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
1.6 | 4.7 | GO:0060988 | lipid tube assembly(GO:0060988) |
1.6 | 1.6 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
1.6 | 4.7 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
1.6 | 21.8 | GO:0043304 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
1.6 | 3.1 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
1.6 | 4.7 | GO:0006543 | glutamine catabolic process(GO:0006543) |
1.5 | 17.0 | GO:0015858 | nucleoside transport(GO:0015858) |
1.5 | 21.7 | GO:0019682 | pentose-phosphate shunt(GO:0006098) glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
1.5 | 1.5 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
1.5 | 4.6 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
1.5 | 4.6 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
1.5 | 15.4 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
1.5 | 9.2 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
1.5 | 18.4 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
1.5 | 9.2 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
1.5 | 4.6 | GO:2000778 | positive regulation of interleukin-6 secretion(GO:2000778) |
1.5 | 3.1 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
1.5 | 7.6 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
1.5 | 4.6 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
1.5 | 10.6 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
1.5 | 4.5 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
1.5 | 4.5 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
1.5 | 6.0 | GO:0051697 | protein delipidation(GO:0051697) |
1.5 | 3.0 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
1.5 | 17.9 | GO:0072678 | T cell migration(GO:0072678) |
1.5 | 3.0 | GO:0060099 | regulation of phagocytosis, engulfment(GO:0060099) |
1.5 | 1.5 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
1.5 | 4.4 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
1.5 | 1.5 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
1.5 | 4.4 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
1.5 | 1.5 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
1.5 | 7.4 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
1.5 | 5.9 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
1.5 | 7.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
1.5 | 4.4 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
1.5 | 4.4 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
1.5 | 4.4 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
1.5 | 1.5 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
1.5 | 4.4 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
1.5 | 5.8 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
1.5 | 2.9 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
1.5 | 30.5 | GO:0045576 | mast cell activation(GO:0045576) |
1.4 | 2.9 | GO:0070268 | cornification(GO:0070268) |
1.4 | 4.3 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
1.4 | 1.4 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
1.4 | 2.9 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
1.4 | 2.9 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
1.4 | 1.4 | GO:2000515 | negative regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043371) negative regulation of T-helper cell differentiation(GO:0045623) negative regulation of CD4-positive, alpha-beta T cell activation(GO:2000515) |
1.4 | 4.3 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
1.4 | 7.2 | GO:1901563 | response to camptothecin(GO:1901563) |
1.4 | 15.8 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
1.4 | 7.1 | GO:0051639 | actin filament network formation(GO:0051639) |
1.4 | 15.6 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
1.4 | 4.2 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
1.4 | 7.1 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
1.4 | 7.1 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
1.4 | 14.1 | GO:0045730 | respiratory burst(GO:0045730) |
1.4 | 2.8 | GO:0006907 | pinocytosis(GO:0006907) |
1.4 | 25.3 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
1.4 | 23.7 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
1.4 | 8.4 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
1.4 | 1.4 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
1.4 | 5.6 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
1.4 | 1.4 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
1.4 | 8.3 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
1.4 | 9.7 | GO:0051352 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
1.4 | 24.8 | GO:0042832 | defense response to protozoan(GO:0042832) |
1.4 | 1.4 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
1.4 | 4.1 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
1.4 | 6.8 | GO:0043589 | skin morphogenesis(GO:0043589) |
1.4 | 4.1 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
1.4 | 9.6 | GO:0060613 | fat pad development(GO:0060613) |
1.4 | 4.1 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
1.4 | 2.7 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
1.4 | 6.8 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
1.4 | 4.1 | GO:0044144 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
1.4 | 2.7 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
1.4 | 4.1 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
1.4 | 1.4 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
1.4 | 10.8 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
1.4 | 1.4 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
1.4 | 4.1 | GO:0006624 | vacuolar protein processing(GO:0006624) |
1.4 | 4.1 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
1.3 | 5.4 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
1.3 | 8.1 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
1.3 | 4.0 | GO:0031577 | spindle checkpoint(GO:0031577) |
1.3 | 1.3 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
1.3 | 17.4 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
1.3 | 4.0 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
1.3 | 2.7 | GO:0060442 | branching involved in prostate gland morphogenesis(GO:0060442) |
1.3 | 4.0 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
1.3 | 10.6 | GO:0044794 | positive regulation by host of viral process(GO:0044794) |
1.3 | 1.3 | GO:0031652 | positive regulation of heat generation(GO:0031652) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
1.3 | 6.6 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
1.3 | 1.3 | GO:0042148 | strand invasion(GO:0042148) |
1.3 | 17.2 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
1.3 | 5.3 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
1.3 | 1.3 | GO:0060416 | response to growth hormone(GO:0060416) |
1.3 | 3.9 | GO:0048143 | astrocyte activation(GO:0048143) |
1.3 | 2.6 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
1.3 | 1.3 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
1.3 | 19.6 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
1.3 | 2.6 | GO:0001562 | response to protozoan(GO:0001562) |
1.3 | 3.9 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
1.3 | 2.6 | GO:0072672 | neutrophil extravasation(GO:0072672) |
1.3 | 2.6 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
1.3 | 1.3 | GO:0072718 | response to cisplatin(GO:0072718) |
1.3 | 7.7 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
1.3 | 7.7 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
1.3 | 2.6 | GO:0015670 | carbon dioxide transport(GO:0015670) |
1.3 | 1.3 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
1.3 | 7.7 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
1.3 | 10.2 | GO:0006590 | thyroid hormone generation(GO:0006590) |
1.3 | 2.6 | GO:0060463 | lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
1.3 | 2.6 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
1.3 | 3.8 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
1.3 | 3.8 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
1.3 | 1.3 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
1.3 | 6.3 | GO:0016574 | histone ubiquitination(GO:0016574) |
1.3 | 2.5 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
1.2 | 2.5 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
1.2 | 13.7 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
1.2 | 2.5 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
1.2 | 5.0 | GO:1900193 | regulation of oocyte maturation(GO:1900193) |
1.2 | 2.5 | GO:0070166 | enamel mineralization(GO:0070166) |
1.2 | 2.5 | GO:0042424 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
1.2 | 3.7 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
1.2 | 8.7 | GO:0046085 | adenosine metabolic process(GO:0046085) |
1.2 | 15.0 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
1.2 | 3.7 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
1.2 | 7.5 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
1.2 | 9.9 | GO:0043687 | post-translational protein modification(GO:0043687) |
1.2 | 5.0 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) |
1.2 | 3.7 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
1.2 | 9.8 | GO:0007135 | meiosis II(GO:0007135) |
1.2 | 4.9 | GO:0007144 | female meiosis I(GO:0007144) |
1.2 | 4.9 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
1.2 | 3.7 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
1.2 | 3.7 | GO:0072012 | glomerulus vasculature development(GO:0072012) |
1.2 | 1.2 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
1.2 | 2.4 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
1.2 | 3.7 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
1.2 | 1.2 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
1.2 | 6.1 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
1.2 | 3.6 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
1.2 | 3.6 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
1.2 | 6.0 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
1.2 | 3.6 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
1.2 | 4.8 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
1.2 | 1.2 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
1.2 | 4.8 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
1.2 | 8.4 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
1.2 | 1.2 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
1.2 | 2.4 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
1.2 | 1.2 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
1.2 | 2.4 | GO:0002158 | osteoclast proliferation(GO:0002158) |
1.2 | 1.2 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
1.2 | 1.2 | GO:0032682 | negative regulation of chemokine production(GO:0032682) |
1.2 | 5.9 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
1.2 | 39.1 | GO:0051306 | mitotic sister chromatid separation(GO:0051306) |
1.2 | 3.5 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
1.2 | 1.2 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
1.2 | 2.4 | GO:0023021 | termination of signal transduction(GO:0023021) |
1.2 | 2.4 | GO:0070741 | response to interleukin-6(GO:0070741) |
1.2 | 1.2 | GO:0090077 | foam cell differentiation(GO:0090077) |
1.2 | 9.4 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
1.2 | 4.7 | GO:0048539 | bone marrow development(GO:0048539) |
1.2 | 1.2 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
1.2 | 10.5 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
1.2 | 9.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
1.2 | 3.5 | GO:0035524 | proline transmembrane transport(GO:0035524) |
1.2 | 20.9 | GO:0043297 | apical junction assembly(GO:0043297) |
1.2 | 3.5 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) |
1.2 | 2.3 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
1.2 | 1.2 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
1.2 | 2.3 | GO:0010039 | response to iron ion(GO:0010039) |
1.2 | 4.6 | GO:0006449 | regulation of translational termination(GO:0006449) |
1.2 | 1.2 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
1.2 | 23.1 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
1.2 | 18.5 | GO:0060711 | labyrinthine layer development(GO:0060711) |
1.2 | 1.2 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
1.2 | 2.3 | GO:0046865 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
1.2 | 1.2 | GO:1902222 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
1.1 | 2.3 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
1.1 | 4.6 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
1.1 | 5.7 | GO:0048821 | erythrocyte development(GO:0048821) |
1.1 | 3.4 | GO:0035973 | aggrephagy(GO:0035973) |
1.1 | 8.0 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
1.1 | 4.6 | GO:1903278 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
1.1 | 1.1 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
1.1 | 2.3 | GO:0045332 | phospholipid translocation(GO:0045332) |
1.1 | 1.1 | GO:0045342 | MHC class II biosynthetic process(GO:0045342) |
1.1 | 3.4 | GO:0031579 | membrane raft organization(GO:0031579) |
1.1 | 2.3 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
1.1 | 2.3 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
1.1 | 5.7 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
1.1 | 7.9 | GO:0006555 | methionine metabolic process(GO:0006555) methionine biosynthetic process(GO:0009086) |
1.1 | 3.4 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
1.1 | 2.3 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
1.1 | 3.4 | GO:0006000 | fructose metabolic process(GO:0006000) |
1.1 | 2.3 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
1.1 | 16.9 | GO:0035456 | response to interferon-beta(GO:0035456) |
1.1 | 2.2 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
1.1 | 6.7 | GO:0046688 | response to copper ion(GO:0046688) |
1.1 | 6.7 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
1.1 | 2.2 | GO:0046016 | positive regulation of transcription by glucose(GO:0046016) |
1.1 | 1.1 | GO:0060760 | positive regulation of response to cytokine stimulus(GO:0060760) |
1.1 | 12.3 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
1.1 | 4.5 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
1.1 | 2.2 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
1.1 | 4.4 | GO:0045792 | negative regulation of cell size(GO:0045792) |
1.1 | 1.1 | GO:0071455 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
1.1 | 1.1 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
1.1 | 4.4 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
1.1 | 4.4 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
1.1 | 35.3 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
1.1 | 11.0 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
1.1 | 6.6 | GO:0035608 | protein deglutamylation(GO:0035608) |
1.1 | 1.1 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
1.1 | 4.4 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
1.1 | 3.3 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
1.1 | 3.3 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
1.1 | 2.2 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
1.1 | 1.1 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
1.1 | 14.1 | GO:0044783 | G1 DNA damage checkpoint(GO:0044783) |
1.1 | 4.3 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
1.1 | 4.3 | GO:0035590 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) purinergic nucleotide receptor signaling pathway(GO:0035590) |
1.1 | 24.8 | GO:0010761 | fibroblast migration(GO:0010761) |
1.1 | 7.5 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
1.1 | 10.8 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
1.1 | 17.2 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
1.1 | 18.3 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
1.1 | 23.7 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
1.1 | 2.1 | GO:0099515 | actin filament-based transport(GO:0099515) |
1.1 | 1.1 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
1.1 | 1.1 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
1.1 | 6.4 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
1.1 | 11.7 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
1.1 | 5.3 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
1.1 | 11.7 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
1.1 | 5.3 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
1.1 | 12.7 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
1.1 | 1.1 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
1.1 | 1.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
1.1 | 4.2 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
1.1 | 7.4 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
1.1 | 27.4 | GO:0006611 | protein export from nucleus(GO:0006611) |
1.0 | 8.4 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
1.0 | 2.1 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
1.0 | 12.5 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
1.0 | 3.1 | GO:0016115 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
1.0 | 12.4 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
1.0 | 2.1 | GO:0098535 | de novo centriole assembly(GO:0098535) |
1.0 | 12.4 | GO:0002639 | positive regulation of immunoglobulin production(GO:0002639) |
1.0 | 2.1 | GO:0021571 | rhombomere 5 development(GO:0021571) |
1.0 | 8.2 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
1.0 | 26.8 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
1.0 | 1.0 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
1.0 | 4.1 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
1.0 | 3.1 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
1.0 | 1.0 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
1.0 | 1.0 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
1.0 | 7.1 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
1.0 | 3.1 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
1.0 | 21.3 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
1.0 | 3.0 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
1.0 | 1.0 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
1.0 | 12.1 | GO:0045116 | protein neddylation(GO:0045116) |
1.0 | 4.0 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
1.0 | 9.0 | GO:0018904 | ether metabolic process(GO:0018904) |
1.0 | 1.0 | GO:0060591 | chondroblast differentiation(GO:0060591) |
1.0 | 4.0 | GO:0033623 | regulation of integrin activation(GO:0033623) |
1.0 | 6.9 | GO:0006560 | proline metabolic process(GO:0006560) |
1.0 | 22.8 | GO:0001892 | embryonic placenta development(GO:0001892) |
1.0 | 1.0 | GO:0034405 | response to fluid shear stress(GO:0034405) |
1.0 | 3.0 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
1.0 | 3.0 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
1.0 | 2.0 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
1.0 | 8.9 | GO:0032801 | receptor catabolic process(GO:0032801) |
1.0 | 2.9 | GO:0006768 | biotin metabolic process(GO:0006768) |
1.0 | 2.9 | GO:0018094 | protein polyglycylation(GO:0018094) |
1.0 | 10.8 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
1.0 | 8.8 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
1.0 | 5.9 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
1.0 | 3.9 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
1.0 | 1.9 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
1.0 | 8.7 | GO:0051383 | kinetochore organization(GO:0051383) |
1.0 | 3.9 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
1.0 | 2.9 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
1.0 | 2.9 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
1.0 | 2.9 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
1.0 | 1.0 | GO:0021603 | cranial nerve formation(GO:0021603) |
1.0 | 3.8 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
1.0 | 3.8 | GO:0009074 | aromatic amino acid family catabolic process(GO:0009074) |
1.0 | 1.0 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
1.0 | 1.9 | GO:0032252 | secretory granule localization(GO:0032252) |
1.0 | 1.0 | GO:0048478 | replication fork protection(GO:0048478) |
1.0 | 1.0 | GO:0070227 | lymphocyte apoptotic process(GO:0070227) |
1.0 | 1.0 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
1.0 | 6.7 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.9 | 0.9 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.9 | 1.9 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.9 | 9.4 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.9 | 2.8 | GO:1904355 | regulation of telomere capping(GO:1904353) positive regulation of telomere capping(GO:1904355) |
0.9 | 1.9 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.9 | 1.9 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.9 | 2.8 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.9 | 2.8 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.9 | 3.7 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.9 | 0.9 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.9 | 2.8 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.9 | 2.8 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.9 | 7.4 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.9 | 2.7 | GO:0050820 | positive regulation of coagulation(GO:0050820) |
0.9 | 6.4 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.9 | 2.7 | GO:0051013 | microtubule severing(GO:0051013) |
0.9 | 0.9 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.9 | 4.5 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.9 | 4.5 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.9 | 1.8 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.9 | 4.5 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.9 | 3.6 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.9 | 3.6 | GO:0034063 | stress granule assembly(GO:0034063) |
0.9 | 0.9 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.9 | 26.6 | GO:0007569 | cell aging(GO:0007569) |
0.9 | 0.9 | GO:0006685 | sphingomyelin metabolic process(GO:0006684) sphingomyelin catabolic process(GO:0006685) |
0.9 | 3.5 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.9 | 1.8 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.9 | 3.5 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.9 | 7.0 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.9 | 3.5 | GO:0000237 | leptotene(GO:0000237) |
0.9 | 4.4 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.9 | 1.8 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.9 | 11.4 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.9 | 3.5 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.9 | 11.4 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.9 | 1.7 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.9 | 7.0 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.9 | 0.9 | GO:0043558 | regulation of translational initiation in response to stress(GO:0043558) |
0.9 | 5.2 | GO:0050729 | positive regulation of inflammatory response(GO:0050729) |
0.9 | 3.5 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.9 | 4.3 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.9 | 0.9 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.9 | 1.7 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.9 | 5.2 | GO:0042116 | macrophage activation(GO:0042116) |
0.9 | 2.6 | GO:0001555 | oocyte growth(GO:0001555) |
0.9 | 0.9 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.9 | 6.0 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.9 | 6.0 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.9 | 1.7 | GO:0060736 | prostate gland growth(GO:0060736) |
0.9 | 3.4 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.9 | 0.9 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.8 | 4.2 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.8 | 5.1 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.8 | 0.8 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.8 | 0.8 | GO:0006266 | DNA ligation(GO:0006266) |
0.8 | 17.7 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
0.8 | 4.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.8 | 0.8 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.8 | 5.0 | GO:0016556 | mRNA modification(GO:0016556) |
0.8 | 2.5 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.8 | 5.0 | GO:0051026 | chiasma assembly(GO:0051026) |
0.8 | 8.3 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.8 | 0.8 | GO:1902548 | negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.8 | 0.8 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.8 | 3.3 | GO:0051031 | tRNA transport(GO:0051031) |
0.8 | 2.5 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.8 | 0.8 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.8 | 4.9 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) positive regulation of glycogen metabolic process(GO:0070875) |
0.8 | 4.9 | GO:0010225 | response to UV-C(GO:0010225) |
0.8 | 5.7 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.8 | 4.1 | GO:0030220 | platelet formation(GO:0030220) |
0.8 | 1.6 | GO:0030421 | defecation(GO:0030421) |
0.8 | 0.8 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.8 | 0.8 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.8 | 3.2 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.8 | 5.6 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.8 | 5.6 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.8 | 0.8 | GO:0032306 | regulation of prostaglandin secretion(GO:0032306) |
0.8 | 4.0 | GO:0046415 | urate metabolic process(GO:0046415) |
0.8 | 1.6 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.8 | 6.4 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.8 | 6.4 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.8 | 0.8 | GO:0060544 | regulation of necroptotic process(GO:0060544) |
0.8 | 0.8 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.8 | 1.6 | GO:0070266 | necroptotic process(GO:0070266) |
0.8 | 2.4 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.8 | 1.6 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.8 | 2.4 | GO:0019532 | oxalate transport(GO:0019532) |
0.8 | 0.8 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.8 | 4.7 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.8 | 3.2 | GO:0016266 | O-glycan processing(GO:0016266) |
0.8 | 0.8 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.8 | 3.1 | GO:0002507 | tolerance induction(GO:0002507) |
0.8 | 2.4 | GO:1902931 | negative regulation of alcohol biosynthetic process(GO:1902931) |
0.8 | 2.3 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.8 | 6.2 | GO:0006458 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.8 | 3.1 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.8 | 0.8 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.8 | 7.0 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.8 | 6.2 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.8 | 3.1 | GO:0046473 | phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
0.8 | 3.9 | GO:0061515 | myeloid cell development(GO:0061515) |
0.8 | 1.5 | GO:0060281 | regulation of oocyte development(GO:0060281) |
0.8 | 3.1 | GO:1902415 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.8 | 0.8 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.8 | 1.5 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.8 | 6.9 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.8 | 0.8 | GO:0038061 | NIK/NF-kappaB signaling(GO:0038061) |
0.8 | 5.3 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.8 | 3.8 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.8 | 0.8 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.8 | 0.8 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
0.8 | 1.5 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.7 | 1.5 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.7 | 4.5 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.7 | 1.5 | GO:0015889 | cobalamin transport(GO:0015889) |
0.7 | 1.5 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.7 | 8.8 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.7 | 0.7 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.7 | 2.2 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.7 | 2.9 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.7 | 1.5 | GO:0009624 | response to nematode(GO:0009624) |
0.7 | 2.2 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.7 | 2.2 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.7 | 2.2 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.7 | 1.5 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.7 | 2.9 | GO:0061028 | establishment of endothelial barrier(GO:0061028) |
0.7 | 1.5 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.7 | 0.7 | GO:0051023 | regulation of immunoglobulin secretion(GO:0051023) |
0.7 | 0.7 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.7 | 1.4 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.7 | 0.7 | GO:0006862 | nucleotide transport(GO:0006862) |
0.7 | 0.7 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.7 | 1.4 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.7 | 19.4 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.7 | 12.9 | GO:0016180 | snRNA processing(GO:0016180) |
0.7 | 1.4 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.7 | 0.7 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.7 | 2.9 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.7 | 2.1 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.7 | 1.4 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.7 | 0.7 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.7 | 3.5 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.7 | 12.0 | GO:0002224 | toll-like receptor signaling pathway(GO:0002224) |
0.7 | 0.7 | GO:1990144 | intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.7 | 3.5 | GO:0042095 | interferon-gamma biosynthetic process(GO:0042095) |
0.7 | 1.4 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.7 | 0.7 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) |
0.7 | 2.8 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.7 | 2.8 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.7 | 8.4 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.7 | 3.5 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.7 | 0.7 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.7 | 9.8 | GO:0007602 | phototransduction(GO:0007602) |
0.7 | 1.4 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.7 | 2.1 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.7 | 4.2 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.7 | 1.4 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.7 | 17.2 | GO:0030168 | platelet activation(GO:0030168) |
0.7 | 0.7 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.7 | 0.7 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.7 | 2.0 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.7 | 1.4 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.7 | 2.7 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.7 | 2.0 | GO:0007097 | nuclear migration(GO:0007097) |
0.7 | 7.4 | GO:0006301 | postreplication repair(GO:0006301) |
0.7 | 0.7 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.7 | 3.4 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.7 | 0.7 | GO:0061724 | lipophagy(GO:0061724) |
0.7 | 1.3 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.7 | 1.3 | GO:0033574 | response to testosterone(GO:0033574) |
0.7 | 2.0 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.7 | 5.3 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.7 | 3.3 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.7 | 2.6 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.7 | 2.0 | GO:0019346 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.7 | 1.3 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.7 | 2.6 | GO:0015871 | choline transport(GO:0015871) |
0.7 | 1.3 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.7 | 2.0 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.7 | 1.3 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.7 | 2.0 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.7 | 2.0 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.7 | 1.3 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.7 | 7.2 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.7 | 0.7 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.7 | 2.6 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.7 | 0.7 | GO:0032909 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.7 | 0.7 | GO:0085020 | protein K27-linked ubiquitination(GO:0044314) protein K6-linked ubiquitination(GO:0085020) |
0.7 | 13.0 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.7 | 2.0 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.7 | 3.3 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.6 | 1.3 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.6 | 0.6 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.6 | 17.3 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.6 | 3.8 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.6 | 1.3 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.6 | 0.6 | GO:0090199 | regulation of release of cytochrome c from mitochondria(GO:0090199) |
0.6 | 10.1 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.6 | 5.1 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.6 | 0.6 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.6 | 0.6 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.6 | 1.3 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.6 | 3.1 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.6 | 1.3 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.6 | 12.5 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.6 | 4.4 | GO:0030575 | nuclear body organization(GO:0030575) |
0.6 | 0.6 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.6 | 0.6 | GO:0036124 | histone H3-K9 trimethylation(GO:0036124) |
0.6 | 0.6 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.6 | 4.3 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.6 | 1.2 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.6 | 6.2 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.6 | 4.3 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.6 | 1.2 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.6 | 1.2 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
0.6 | 3.7 | GO:0051304 | chromosome separation(GO:0051304) |
0.6 | 2.5 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.6 | 1.8 | GO:0010165 | response to X-ray(GO:0010165) |
0.6 | 1.2 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.6 | 0.6 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.6 | 8.5 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.6 | 3.7 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.6 | 0.6 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.6 | 5.4 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.6 | 2.4 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.6 | 1.8 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.6 | 3.6 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.6 | 0.6 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.6 | 5.4 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.6 | 3.6 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.6 | 1.2 | GO:0019042 | viral latency(GO:0019042) |
0.6 | 1.2 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.6 | 3.6 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.6 | 0.6 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.6 | 1.2 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.6 | 7.1 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.6 | 5.3 | GO:0046348 | amino sugar catabolic process(GO:0046348) |
0.6 | 19.0 | GO:0007599 | hemostasis(GO:0007599) |
0.6 | 3.0 | GO:0019079 | viral genome replication(GO:0019079) |
0.6 | 1.8 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.6 | 1.8 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.6 | 0.6 | GO:0071218 | response to misfolded protein(GO:0051788) cellular response to misfolded protein(GO:0071218) |
0.6 | 1.8 | GO:0090312 | positive regulation of protein deacetylation(GO:0090312) |
0.6 | 4.7 | GO:0003170 | heart valve development(GO:0003170) |
0.6 | 4.1 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.6 | 6.9 | GO:0030239 | myofibril assembly(GO:0030239) |
0.6 | 0.6 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.6 | 22.5 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.6 | 1.7 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.6 | 12.7 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.6 | 0.6 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.6 | 1.2 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.6 | 1.7 | GO:0051693 | actin filament capping(GO:0051693) |
0.6 | 2.3 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.6 | 5.1 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.6 | 2.8 | GO:0070232 | regulation of T cell apoptotic process(GO:0070232) |
0.6 | 31.3 | GO:0043122 | regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043122) |
0.6 | 5.7 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.6 | 1.7 | GO:0048525 | negative regulation of viral process(GO:0048525) |
0.6 | 1.1 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.6 | 0.6 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.6 | 1.1 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.6 | 2.2 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.6 | 2.8 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.6 | 0.6 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.6 | 1.7 | GO:0009309 | amine biosynthetic process(GO:0009309) cellular biogenic amine biosynthetic process(GO:0042401) |
0.6 | 2.2 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.6 | 1.7 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.6 | 0.6 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.6 | 1.1 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.6 | 1.7 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.5 | 1.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.5 | 2.2 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
0.5 | 3.8 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.5 | 4.4 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.5 | 2.2 | GO:0006265 | DNA topological change(GO:0006265) |
0.5 | 1.1 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.5 | 1.6 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.5 | 2.7 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.5 | 6.0 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.5 | 0.5 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.5 | 2.7 | GO:1904385 | cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
0.5 | 0.5 | GO:0009750 | response to fructose(GO:0009750) cellular response to fructose stimulus(GO:0071332) |
0.5 | 2.2 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.5 | 1.6 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.5 | 1.6 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.5 | 4.8 | GO:0014850 | response to muscle activity(GO:0014850) |
0.5 | 0.5 | GO:0048302 | isotype switching to IgG isotypes(GO:0048291) regulation of isotype switching to IgG isotypes(GO:0048302) |
0.5 | 1.6 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.5 | 1.6 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.5 | 0.5 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.5 | 1.6 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.5 | 0.5 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.5 | 2.7 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.5 | 1.1 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.5 | 0.5 | GO:0033034 | positive regulation of myeloid cell apoptotic process(GO:0033034) |
0.5 | 8.0 | GO:0030488 | tRNA methylation(GO:0030488) |
0.5 | 1.1 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.5 | 0.5 | GO:0007567 | parturition(GO:0007567) |
0.5 | 0.5 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.5 | 3.7 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.5 | 1.6 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.5 | 1.0 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.5 | 15.6 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.5 | 5.7 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.5 | 1.0 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.5 | 1.6 | GO:0051459 | regulation of corticotropin secretion(GO:0051459) |
0.5 | 1.5 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.5 | 2.1 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.5 | 1.0 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.5 | 1.5 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.5 | 0.5 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.5 | 1.5 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.5 | 0.5 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.5 | 2.5 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.5 | 2.0 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.5 | 26.2 | GO:0051028 | mRNA transport(GO:0051028) |
0.5 | 2.0 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
0.5 | 8.0 | GO:0001783 | B cell apoptotic process(GO:0001783) |
0.5 | 16.1 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.5 | 4.0 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.5 | 1.5 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.5 | 2.0 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.5 | 0.5 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.5 | 1.0 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.5 | 5.4 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.5 | 0.5 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.5 | 6.4 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.5 | 4.9 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.5 | 2.4 | GO:0006968 | cellular defense response(GO:0006968) |
0.5 | 0.5 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.5 | 3.4 | GO:0031648 | protein destabilization(GO:0031648) |
0.5 | 3.4 | GO:0002251 | organ or tissue specific immune response(GO:0002251) |
0.5 | 10.1 | GO:0006284 | base-excision repair(GO:0006284) |
0.5 | 1.4 | GO:0060438 | trachea development(GO:0060438) |
0.5 | 1.9 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.5 | 1.4 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.5 | 0.5 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.5 | 28.7 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.5 | 4.7 | GO:0050892 | intestinal absorption(GO:0050892) |
0.5 | 0.5 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.5 | 1.9 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.5 | 0.5 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.5 | 1.4 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.5 | 1.4 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.5 | 7.0 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.5 | 2.3 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.5 | 3.7 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.5 | 0.5 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.5 | 0.5 | GO:0032196 | transposition(GO:0032196) |
0.5 | 0.9 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.5 | 0.9 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.5 | 3.2 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.5 | 1.4 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.5 | 4.5 | GO:0043631 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.4 | 0.9 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.4 | 0.9 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.4 | 1.3 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.4 | 0.9 | GO:0098754 | detoxification(GO:0098754) |
0.4 | 1.3 | GO:0006273 | lagging strand elongation(GO:0006273) |
0.4 | 0.9 | GO:0000012 | single strand break repair(GO:0000012) |
0.4 | 12.1 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.4 | 2.2 | GO:0009067 | aspartate family amino acid biosynthetic process(GO:0009067) |
0.4 | 0.9 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.4 | 1.3 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.4 | 0.9 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.4 | 0.4 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.4 | 2.2 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.4 | 0.9 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.4 | 1.8 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.4 | 2.6 | GO:0061756 | leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.4 | 0.4 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.4 | 0.4 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.4 | 0.4 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.4 | 3.4 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.4 | 0.4 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.4 | 0.9 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.4 | 0.4 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.4 | 1.3 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.4 | 2.5 | GO:0001945 | lymph vessel development(GO:0001945) |
0.4 | 2.9 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
0.4 | 2.9 | GO:1901984 | negative regulation of protein acetylation(GO:1901984) |
0.4 | 0.8 | GO:0098581 | detection of external biotic stimulus(GO:0098581) |
0.4 | 5.0 | GO:0035690 | cellular response to drug(GO:0035690) |
0.4 | 11.3 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.4 | 1.7 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.4 | 1.3 | GO:0051154 | negative regulation of striated muscle cell differentiation(GO:0051154) |
0.4 | 3.3 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.4 | 1.7 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.4 | 2.1 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.4 | 0.8 | GO:0016137 | glycoside metabolic process(GO:0016137) |
0.4 | 2.1 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.4 | 4.5 | GO:0051168 | nuclear export(GO:0051168) |
0.4 | 6.6 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.4 | 2.1 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.4 | 0.4 | GO:0034969 | histone arginine methylation(GO:0034969) histone H4-R3 methylation(GO:0043985) |
0.4 | 1.6 | GO:0035561 | regulation of chromatin binding(GO:0035561) |
0.4 | 8.2 | GO:0009813 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.4 | 0.4 | GO:0002418 | immune response to tumor cell(GO:0002418) |
0.4 | 0.8 | GO:0043328 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.4 | 0.8 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.4 | 0.4 | GO:0071402 | cellular response to lipoprotein particle stimulus(GO:0071402) |
0.4 | 0.8 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.4 | 0.4 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.4 | 1.6 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.4 | 1.6 | GO:1903573 | negative regulation of response to endoplasmic reticulum stress(GO:1903573) |
0.4 | 0.4 | GO:0009301 | snRNA transcription(GO:0009301) |
0.4 | 4.0 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.4 | 3.6 | GO:0001675 | acrosome assembly(GO:0001675) |
0.4 | 1.6 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.4 | 2.0 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.4 | 1.6 | GO:0042168 | heme metabolic process(GO:0042168) |
0.4 | 1.2 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.4 | 7.1 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.4 | 0.8 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.4 | 2.3 | GO:0045621 | positive regulation of lymphocyte differentiation(GO:0045621) |
0.4 | 3.1 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.4 | 3.9 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.4 | 0.8 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.4 | 2.7 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.4 | 0.8 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.4 | 3.4 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.4 | 0.4 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.4 | 0.8 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.4 | 0.4 | GO:1903242 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
0.4 | 0.4 | GO:2000316 | regulation of T-helper 17 type immune response(GO:2000316) |
0.4 | 0.4 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.4 | 0.4 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.4 | 0.4 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.4 | 1.1 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.4 | 4.5 | GO:0060325 | face morphogenesis(GO:0060325) |
0.4 | 1.5 | GO:0032800 | receptor biosynthetic process(GO:0032800) |
0.4 | 0.4 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.4 | 7.4 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.4 | 13.3 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.4 | 1.8 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.4 | 2.9 | GO:0070206 | protein trimerization(GO:0070206) |
0.4 | 2.9 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.4 | 0.4 | GO:0018158 | protein oxidation(GO:0018158) |
0.4 | 1.1 | GO:0030316 | osteoclast differentiation(GO:0030316) |
0.4 | 1.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.4 | 0.4 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.4 | 0.7 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.4 | 0.4 | GO:0048340 | paraxial mesoderm morphogenesis(GO:0048340) |
0.4 | 1.1 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.4 | 1.4 | GO:1901186 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.4 | 0.7 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.4 | 0.7 | GO:0090671 | RNA localization to Cajal body(GO:0090670) telomerase RNA localization to Cajal body(GO:0090671) telomerase RNA localization(GO:0090672) |
0.4 | 5.3 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.4 | 1.1 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.4 | 1.1 | GO:0042108 | positive regulation of cytokine biosynthetic process(GO:0042108) |
0.3 | 1.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.3 | 1.0 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.3 | 0.3 | GO:0072395 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.3 | 0.3 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.3 | 0.7 | GO:0033572 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.3 | 1.0 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.3 | 0.7 | GO:0050996 | positive regulation of lipid catabolic process(GO:0050996) |
0.3 | 1.7 | GO:0036474 | cell death in response to hydrogen peroxide(GO:0036474) |
0.3 | 1.0 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.3 | 7.9 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.3 | 2.1 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.3 | 0.3 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.3 | 1.4 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.3 | 3.4 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.3 | 1.0 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.3 | 14.6 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.3 | 0.3 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.3 | 3.0 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.3 | 0.3 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.3 | 2.0 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.3 | 6.3 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.3 | 7.6 | GO:0031424 | keratinization(GO:0031424) |
0.3 | 0.7 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.3 | 0.3 | GO:0060967 | negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by miRNA(GO:0060965) negative regulation of gene silencing by RNA(GO:0060967) |
0.3 | 2.3 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
0.3 | 1.3 | GO:1901184 | regulation of ERBB signaling pathway(GO:1901184) |
0.3 | 3.9 | GO:0007004 | RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
0.3 | 1.6 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.3 | 2.6 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.3 | 0.3 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.3 | 1.6 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.3 | 0.3 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.3 | 2.9 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.3 | 0.3 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) |
0.3 | 0.9 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
0.3 | 1.9 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.3 | 0.6 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.3 | 4.9 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.3 | 1.5 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.3 | 3.1 | GO:0006465 | signal peptide processing(GO:0006465) |
0.3 | 3.7 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.3 | 0.9 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.3 | 3.6 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
0.3 | 10.9 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.3 | 3.0 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.3 | 5.1 | GO:0034101 | erythrocyte homeostasis(GO:0034101) |
0.3 | 1.2 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.3 | 0.3 | GO:0009310 | amine catabolic process(GO:0009310) |
0.3 | 1.2 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.3 | 0.3 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.3 | 1.2 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.3 | 0.3 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.3 | 0.3 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.3 | 0.6 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.3 | 3.5 | GO:0006953 | acute-phase response(GO:0006953) |
0.3 | 1.8 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.3 | 1.8 | GO:2001239 | regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001239) |
0.3 | 2.3 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.3 | 0.9 | GO:1903911 | positive regulation of postsynaptic membrane organization(GO:1901628) positive regulation of receptor clustering(GO:1903911) regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
0.3 | 0.9 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.3 | 0.6 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.3 | 2.3 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.3 | 0.6 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.3 | 0.8 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.3 | 0.3 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.3 | 3.1 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.3 | 0.6 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.3 | 0.8 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.3 | 0.3 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.3 | 0.6 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.3 | 0.6 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.3 | 0.5 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.3 | 1.1 | GO:0046365 | monosaccharide catabolic process(GO:0046365) |
0.3 | 0.5 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.3 | 3.3 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.3 | 0.3 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.3 | 0.5 | GO:0060969 | negative regulation of gene silencing(GO:0060969) |
0.3 | 10.1 | GO:0009060 | aerobic respiration(GO:0009060) |
0.3 | 0.3 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.3 | 0.5 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.3 | 0.5 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.3 | 0.8 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.3 | 0.3 | GO:0090501 | RNA phosphodiester bond hydrolysis(GO:0090501) |
0.3 | 1.3 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.3 | 1.3 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.3 | 17.9 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.3 | 0.3 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.3 | 0.3 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.3 | 1.0 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.3 | 0.3 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.3 | 0.5 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.2 | 0.7 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.2 | 0.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.2 | 3.0 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) |
0.2 | 0.7 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.2 | 0.5 | GO:0051784 | negative regulation of nuclear division(GO:0051784) |
0.2 | 0.2 | GO:0009078 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) L-alanine metabolic process(GO:0042851) |
0.2 | 0.2 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.2 | 0.7 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.2 | 9.0 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.2 | 0.5 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.2 | 1.7 | GO:1900744 | regulation of p38MAPK cascade(GO:1900744) |
0.2 | 15.0 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.2 | 0.7 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.2 | 0.7 | GO:0042026 | protein refolding(GO:0042026) |
0.2 | 0.2 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.2 | 0.5 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.2 | 0.5 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.2 | 0.2 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.2 | 1.8 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.2 | 0.2 | GO:0050832 | defense response to fungus(GO:0050832) |
0.2 | 0.5 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.2 | 1.3 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.2 | 0.2 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.2 | 2.6 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 7.2 | GO:0007030 | Golgi organization(GO:0007030) |
0.2 | 0.2 | GO:0034204 | lipid translocation(GO:0034204) |
0.2 | 2.4 | GO:0006959 | humoral immune response(GO:0006959) |
0.2 | 1.3 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.2 | 0.2 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.2 | 1.2 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.2 | 1.0 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.2 | 0.6 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.2 | 0.2 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.2 | 0.2 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.2 | 0.4 | GO:0051972 | regulation of telomerase activity(GO:0051972) |
0.2 | 0.4 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.2 | 0.4 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.2 | 2.0 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.2 | 1.4 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.2 | 0.2 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.2 | 0.6 | GO:0097421 | liver regeneration(GO:0097421) |
0.2 | 0.8 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.2 | 0.2 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.2 | 0.8 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.2 | 0.6 | GO:0051255 | spindle midzone assembly(GO:0051255) |
0.2 | 0.9 | GO:0009249 | protein lipoylation(GO:0009249) |
0.2 | 0.4 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
0.2 | 0.4 | GO:0006983 | ER overload response(GO:0006983) |
0.2 | 0.2 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
0.2 | 0.4 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.2 | 0.7 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.2 | 1.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.2 | 4.1 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.2 | 0.7 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.2 | 0.9 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.2 | 0.5 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.2 | 1.0 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.2 | 0.5 | GO:0043039 | amino acid activation(GO:0043038) tRNA aminoacylation(GO:0043039) |
0.2 | 5.0 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.2 | 0.2 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.2 | 0.9 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.2 | 0.2 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.2 | 0.7 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.2 | 0.8 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 0.3 | GO:0051775 | response to redox state(GO:0051775) |
0.2 | 1.3 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.2 | 1.0 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.2 | 0.3 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.2 | 1.8 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.2 | 0.5 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.2 | 0.5 | GO:0070305 | response to cGMP(GO:0070305) |
0.2 | 0.3 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.2 | 7.9 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.2 | 0.6 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
0.2 | 4.3 | GO:0051225 | spindle assembly(GO:0051225) |
0.2 | 0.5 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.2 | 0.9 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.1 | 12.6 | GO:0016072 | rRNA metabolic process(GO:0016072) |
0.1 | 0.1 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.1 | 0.1 | GO:0051132 | NK T cell activation(GO:0051132) |
0.1 | 0.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 0.7 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.1 | 0.1 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.1 | 3.1 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.1 | 1.0 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.1 | 0.4 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.1 | 0.1 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.1 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) |
0.1 | 0.7 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.1 | 2.3 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.1 | 0.3 | GO:0035947 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) |
0.1 | 0.4 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.1 | 3.8 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.1 | 0.1 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.1 | 1.8 | GO:0046849 | bone remodeling(GO:0046849) |
0.1 | 0.9 | GO:0015893 | drug transport(GO:0015893) |
0.1 | 0.1 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.1 | 0.5 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.1 | 0.8 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.2 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 1.3 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.3 | GO:0048757 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.1 | 0.1 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
0.1 | 0.1 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.1 | 1.4 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.1 | 1.1 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.4 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.2 | GO:0042628 | mating plug formation(GO:0042628) post-mating behavior(GO:0045297) |
0.1 | 0.1 | GO:0033684 | regulation of luteinizing hormone secretion(GO:0033684) negative regulation of luteinizing hormone secretion(GO:0033685) |
0.1 | 0.1 | GO:1901068 | guanosine-containing compound metabolic process(GO:1901068) |
0.1 | 0.2 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.1 | 0.1 | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
0.1 | 0.4 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 2.0 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.1 | 0.2 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 | 0.4 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.1 | 0.2 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.1 | 0.7 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.1 | 0.1 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.3 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.3 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.1 | 0.3 | GO:0070555 | response to interleukin-1(GO:0070555) |
0.1 | 0.5 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.1 | 0.1 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.1 | 0.1 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.1 | 5.1 | GO:0045087 | innate immune response(GO:0045087) |
0.1 | 0.3 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.1 | 0.4 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.1 | 0.2 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.1 | 1.0 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.1 | 0.1 | GO:0009650 | UV protection(GO:0009650) |
0.1 | 0.1 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.1 | 0.1 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.1 | GO:0044838 | cell quiescence(GO:0044838) |
0.1 | 0.2 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.1 | 1.0 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.1 | 0.3 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.1 | 0.6 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.1 | GO:0051593 | response to folic acid(GO:0051593) |
0.1 | 0.2 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.1 | 0.1 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 6.6 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 3.7 | GO:0071216 | cellular response to biotic stimulus(GO:0071216) |
0.1 | 0.1 | GO:1901031 | regulation of response to reactive oxygen species(GO:1901031) |
0.1 | 0.1 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.1 | 0.4 | GO:0006743 | ubiquinone metabolic process(GO:0006743) quinone biosynthetic process(GO:1901663) |
0.1 | 0.1 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.1 | 0.5 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 0.1 | GO:0046909 | intermembrane transport(GO:0046909) |
0.1 | 0.3 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.1 | 0.9 | GO:0009617 | response to bacterium(GO:0009617) |
0.1 | 0.1 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.1 | 0.1 | GO:0009219 | pyrimidine deoxyribonucleotide metabolic process(GO:0009219) deoxyribonucleotide catabolic process(GO:0009264) deoxyribose phosphate catabolic process(GO:0046386) |
0.1 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.1 | GO:0070293 | renal absorption(GO:0070293) |
0.1 | 0.1 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.1 | 0.1 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.1 | 0.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.1 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.1 | 0.2 | GO:0034397 | telomere localization(GO:0034397) |
0.0 | 0.0 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.0 | 0.1 | GO:0042640 | anagen(GO:0042640) |
0.0 | 0.1 | GO:0006739 | NADP metabolic process(GO:0006739) |
0.0 | 0.0 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.0 | 0.2 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.0 | 3.2 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.0 | 0.0 | GO:0007418 | ventral midline development(GO:0007418) floor plate morphogenesis(GO:0033505) |
0.0 | 0.1 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.0 | 0.2 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.0 | 0.0 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
0.0 | 0.2 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.0 | 0.8 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.0 | GO:0006826 | iron ion transport(GO:0006826) |
0.0 | 0.2 | GO:0072527 | pyrimidine-containing compound metabolic process(GO:0072527) |
0.0 | 0.0 | GO:1990266 | neutrophil migration(GO:1990266) |
0.0 | 0.1 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.0 | 0.2 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.0 | 0.1 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.0 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.0 | GO:0042634 | regulation of hair cycle(GO:0042634) |
0.0 | 0.0 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.0 | 0.1 | GO:0006081 | cellular aldehyde metabolic process(GO:0006081) |
0.0 | 0.1 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.2 | 55.2 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
6.5 | 32.5 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
6.1 | 18.4 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
4.9 | 19.7 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
4.8 | 14.3 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
4.6 | 23.2 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
4.4 | 26.3 | GO:0097342 | ripoptosome(GO:0097342) |
4.2 | 4.2 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
4.2 | 33.3 | GO:0005861 | troponin complex(GO:0005861) |
4.1 | 16.6 | GO:0019815 | B cell receptor complex(GO:0019815) |
4.1 | 20.3 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
4.0 | 32.3 | GO:0030056 | hemidesmosome(GO:0030056) |
4.0 | 40.3 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
3.9 | 19.4 | GO:0033093 | Weibel-Palade body(GO:0033093) |
3.9 | 15.5 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
3.7 | 11.1 | GO:0097512 | cardiac myofibril(GO:0097512) |
3.6 | 21.3 | GO:0031983 | vesicle lumen(GO:0031983) |
3.5 | 7.1 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
3.5 | 24.7 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
3.4 | 10.3 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
3.4 | 20.2 | GO:0002139 | stereocilia coupling link(GO:0002139) |
3.3 | 20.1 | GO:0042629 | mast cell granule(GO:0042629) |
3.3 | 13.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
3.3 | 13.0 | GO:0071141 | SMAD protein complex(GO:0071141) |
3.2 | 19.4 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
3.2 | 16.0 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
3.1 | 9.3 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
3.1 | 15.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
3.0 | 6.0 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
3.0 | 30.0 | GO:0002102 | podosome(GO:0002102) |
3.0 | 6.0 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
3.0 | 14.8 | GO:0005859 | muscle myosin complex(GO:0005859) |
3.0 | 14.8 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
2.9 | 8.8 | GO:0097427 | microtubule bundle(GO:0097427) |
2.9 | 5.8 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
2.9 | 8.7 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
2.8 | 11.0 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
2.8 | 19.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
2.7 | 10.9 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
2.7 | 13.6 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
2.7 | 24.4 | GO:0070938 | contractile ring(GO:0070938) |
2.7 | 2.7 | GO:0042613 | MHC class II protein complex(GO:0042613) |
2.6 | 2.6 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
2.5 | 2.5 | GO:0005652 | nuclear lamina(GO:0005652) |
2.5 | 7.4 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
2.4 | 12.1 | GO:0032133 | chromosome passenger complex(GO:0032133) |
2.4 | 29.0 | GO:0031528 | microvillus membrane(GO:0031528) |
2.4 | 16.6 | GO:0090543 | Flemming body(GO:0090543) |
2.3 | 25.5 | GO:0031430 | M band(GO:0031430) |
2.3 | 13.9 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
2.3 | 6.9 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
2.3 | 6.9 | GO:0005642 | annulate lamellae(GO:0005642) |
2.2 | 6.7 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
2.2 | 6.7 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
2.2 | 8.9 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
2.2 | 28.8 | GO:0042581 | specific granule(GO:0042581) |
2.2 | 8.8 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
2.2 | 50.5 | GO:0008305 | integrin complex(GO:0008305) |
2.2 | 17.4 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
2.2 | 6.5 | GO:0005914 | spot adherens junction(GO:0005914) |
2.1 | 8.6 | GO:0030478 | actin cap(GO:0030478) |
2.1 | 8.5 | GO:1990246 | uniplex complex(GO:1990246) |
2.1 | 8.4 | GO:0045180 | basal cortex(GO:0045180) |
2.1 | 2.1 | GO:0032432 | actin filament bundle(GO:0032432) |
2.1 | 6.2 | GO:0005879 | axonemal microtubule(GO:0005879) |
2.0 | 28.6 | GO:0005865 | striated muscle thin filament(GO:0005865) |
2.0 | 16.3 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
2.0 | 81.5 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
2.0 | 12.2 | GO:0001739 | sex chromatin(GO:0001739) |
2.0 | 4.0 | GO:0032127 | dense core granule membrane(GO:0032127) |
2.0 | 6.0 | GO:0070552 | BRISC complex(GO:0070552) |
2.0 | 25.7 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
2.0 | 2.0 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
1.9 | 9.7 | GO:0005579 | membrane attack complex(GO:0005579) |
1.9 | 7.7 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
1.9 | 5.7 | GO:0031523 | Myb complex(GO:0031523) |
1.9 | 7.6 | GO:0042627 | chylomicron(GO:0042627) |
1.9 | 5.7 | GO:0005833 | hemoglobin complex(GO:0005833) |
1.9 | 3.7 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
1.8 | 112.1 | GO:0042641 | actomyosin(GO:0042641) |
1.8 | 7.3 | GO:0070876 | SOSS complex(GO:0070876) |
1.8 | 7.3 | GO:0035189 | Rb-E2F complex(GO:0035189) |
1.8 | 10.9 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
1.8 | 3.5 | GO:0000322 | storage vacuole(GO:0000322) |
1.7 | 5.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.7 | 5.0 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
1.7 | 53.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
1.6 | 4.9 | GO:0005915 | zonula adherens(GO:0005915) |
1.6 | 6.6 | GO:0045293 | mRNA editing complex(GO:0045293) |
1.6 | 3.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
1.6 | 19.6 | GO:0043034 | costamere(GO:0043034) |
1.6 | 26.1 | GO:0000145 | exocyst(GO:0000145) |
1.6 | 11.4 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
1.6 | 14.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
1.6 | 4.9 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
1.6 | 4.9 | GO:0046691 | intracellular canaliculus(GO:0046691) |
1.6 | 6.4 | GO:0097452 | GAIT complex(GO:0097452) |
1.6 | 4.8 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
1.6 | 4.8 | GO:0043259 | laminin-10 complex(GO:0043259) |
1.6 | 4.8 | GO:0042612 | MHC class I protein complex(GO:0042612) |
1.6 | 4.8 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
1.6 | 23.8 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
1.6 | 15.8 | GO:0046581 | intercellular canaliculus(GO:0046581) |
1.6 | 6.3 | GO:0072487 | MSL complex(GO:0072487) |
1.6 | 11.0 | GO:0042382 | paraspeckles(GO:0042382) |
1.6 | 20.4 | GO:0005771 | multivesicular body(GO:0005771) |
1.6 | 14.1 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
1.6 | 4.7 | GO:0005588 | collagen type V trimer(GO:0005588) |
1.5 | 7.7 | GO:0005638 | lamin filament(GO:0005638) |
1.5 | 15.4 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
1.5 | 16.9 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
1.5 | 10.6 | GO:0016600 | flotillin complex(GO:0016600) |
1.5 | 127.6 | GO:0072562 | blood microparticle(GO:0072562) |
1.5 | 3.0 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
1.5 | 8.9 | GO:1990462 | omegasome(GO:1990462) |
1.5 | 8.9 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
1.5 | 19.3 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
1.5 | 37.0 | GO:0001772 | immunological synapse(GO:0001772) |
1.5 | 4.4 | GO:0031094 | platelet dense tubular network(GO:0031094) |
1.5 | 22.1 | GO:0000421 | autophagosome membrane(GO:0000421) |
1.5 | 11.8 | GO:0001650 | fibrillar center(GO:0001650) |
1.5 | 1.5 | GO:0032444 | activin responsive factor complex(GO:0032444) |
1.5 | 7.3 | GO:0016589 | NURF complex(GO:0016589) |
1.5 | 5.8 | GO:0097431 | mitotic spindle pole(GO:0097431) |
1.4 | 5.8 | GO:0000805 | X chromosome(GO:0000805) |
1.4 | 4.3 | GO:0033186 | CAF-1 complex(GO:0033186) |
1.4 | 4.3 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
1.4 | 5.7 | GO:0031010 | ISWI-type complex(GO:0031010) |
1.4 | 2.8 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
1.4 | 78.7 | GO:0000118 | histone deacetylase complex(GO:0000118) |
1.4 | 5.6 | GO:0031429 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
1.4 | 15.1 | GO:0001891 | phagocytic cup(GO:0001891) |
1.4 | 2.7 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
1.4 | 1.4 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
1.4 | 95.8 | GO:0005581 | collagen trimer(GO:0005581) |
1.3 | 2.7 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
1.3 | 9.3 | GO:0031091 | platelet alpha granule(GO:0031091) |
1.3 | 9.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
1.3 | 5.3 | GO:1990130 | Iml1 complex(GO:1990130) |
1.3 | 33.3 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
1.3 | 5.3 | GO:0031298 | replication fork protection complex(GO:0031298) |
1.3 | 18.4 | GO:0031672 | A band(GO:0031672) |
1.3 | 6.6 | GO:0097422 | tubular endosome(GO:0097422) |
1.3 | 10.4 | GO:0031209 | SCAR complex(GO:0031209) |
1.3 | 5.2 | GO:0035339 | SPOTS complex(GO:0035339) |
1.3 | 12.8 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
1.3 | 2.5 | GO:0005828 | kinetochore microtubule(GO:0005828) |
1.3 | 30.5 | GO:0097228 | sperm principal piece(GO:0097228) |
1.2 | 24.5 | GO:0042588 | zymogen granule(GO:0042588) |
1.2 | 4.8 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
1.2 | 7.2 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
1.2 | 9.6 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
1.2 | 63.5 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
1.2 | 101.7 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
1.2 | 3.6 | GO:0048179 | activin receptor complex(GO:0048179) |
1.2 | 3.5 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
1.2 | 9.3 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
1.2 | 5.8 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
1.1 | 1.1 | GO:0071438 | invadopodium membrane(GO:0071438) |
1.1 | 11.4 | GO:0005916 | fascia adherens(GO:0005916) |
1.1 | 1.1 | GO:0000814 | ESCRT II complex(GO:0000814) |
1.1 | 5.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
1.1 | 2.2 | GO:0097413 | Lewy body(GO:0097413) |
1.1 | 5.6 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
1.1 | 2.2 | GO:0033263 | CORVET complex(GO:0033263) |
1.1 | 8.9 | GO:0031616 | spindle pole centrosome(GO:0031616) |
1.1 | 4.4 | GO:0005726 | perichromatin fibrils(GO:0005726) |
1.1 | 34.0 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
1.1 | 3.3 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
1.1 | 3.2 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
1.1 | 16.1 | GO:0043218 | compact myelin(GO:0043218) |
1.1 | 9.6 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
1.1 | 3.2 | GO:0097443 | sorting endosome(GO:0097443) |
1.1 | 3.2 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
1.1 | 11.7 | GO:0010369 | chromocenter(GO:0010369) |
1.1 | 9.5 | GO:0097542 | ciliary tip(GO:0097542) |
1.1 | 3.2 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
1.0 | 6.2 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.0 | 1.0 | GO:0005682 | U5 snRNP(GO:0005682) |
1.0 | 7.1 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
1.0 | 1.0 | GO:0030686 | 90S preribosome(GO:0030686) |
1.0 | 3.0 | GO:1990423 | RZZ complex(GO:1990423) |
1.0 | 13.1 | GO:1990204 | oxidoreductase complex(GO:1990204) |
1.0 | 17.0 | GO:0030057 | desmosome(GO:0030057) |
1.0 | 2.0 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
1.0 | 41.5 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
1.0 | 2.9 | GO:0097149 | centralspindlin complex(GO:0097149) |
1.0 | 2.9 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
1.0 | 2.9 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
1.0 | 2.0 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
1.0 | 4.9 | GO:0031143 | pseudopodium(GO:0031143) |
1.0 | 7.7 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
1.0 | 2.9 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.9 | 7.6 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.9 | 212.5 | GO:0005925 | focal adhesion(GO:0005925) |
0.9 | 0.9 | GO:0043293 | apoptosome(GO:0043293) |
0.9 | 12.2 | GO:0038201 | TOR complex(GO:0038201) |
0.9 | 6.6 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.9 | 3.7 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.9 | 0.9 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.9 | 9.3 | GO:0032039 | integrator complex(GO:0032039) |
0.9 | 49.9 | GO:0016605 | PML body(GO:0016605) |
0.9 | 3.7 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.9 | 8.3 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.9 | 22.0 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.9 | 1.8 | GO:0030870 | Mre11 complex(GO:0030870) |
0.9 | 3.6 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.9 | 36.2 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.9 | 3.6 | GO:0042583 | chromaffin granule(GO:0042583) |
0.9 | 8.9 | GO:0005643 | nuclear pore(GO:0005643) |
0.9 | 7.1 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.9 | 190.9 | GO:0005667 | transcription factor complex(GO:0005667) |
0.9 | 2.6 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.9 | 2.6 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.9 | 2.6 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.9 | 16.3 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.9 | 0.9 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.9 | 7.7 | GO:0042555 | MCM complex(GO:0042555) |
0.9 | 76.5 | GO:0000793 | condensed chromosome(GO:0000793) |
0.8 | 4.2 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.8 | 23.7 | GO:0005938 | cell cortex(GO:0005938) |
0.8 | 7.6 | GO:0005614 | interstitial matrix(GO:0005614) |
0.8 | 8.3 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.8 | 1.6 | GO:0016939 | kinesin II complex(GO:0016939) |
0.8 | 17.7 | GO:0016592 | mediator complex(GO:0016592) |
0.8 | 4.0 | GO:0032982 | myosin filament(GO:0032982) |
0.8 | 1.6 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.8 | 3.9 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.8 | 5.5 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.8 | 3.9 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.8 | 11.6 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.8 | 2.3 | GO:0071953 | elastic fiber(GO:0071953) |
0.8 | 8.5 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.8 | 6.9 | GO:0046930 | pore complex(GO:0046930) |
0.8 | 6.8 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.8 | 0.8 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.7 | 32.1 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.7 | 29.0 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.7 | 1.5 | GO:0031902 | late endosome membrane(GO:0031902) |
0.7 | 2.9 | GO:0042587 | glycogen granule(GO:0042587) |
0.7 | 8.7 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.7 | 2.2 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.7 | 45.8 | GO:0001726 | ruffle(GO:0001726) |
0.7 | 33.4 | GO:0005819 | spindle(GO:0005819) |
0.7 | 2.9 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.7 | 3.6 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.7 | 35.6 | GO:0005811 | lipid particle(GO:0005811) |
0.7 | 8.6 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.7 | 17.7 | GO:0005876 | spindle microtubule(GO:0005876) |
0.7 | 16.9 | GO:0016459 | myosin complex(GO:0016459) |
0.7 | 7.7 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.7 | 8.4 | GO:0000242 | pericentriolar material(GO:0000242) |
0.7 | 2.8 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.7 | 3.5 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.7 | 9.0 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.7 | 17.9 | GO:0000502 | proteasome complex(GO:0000502) |
0.7 | 2.7 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.7 | 14.3 | GO:0016363 | nuclear matrix(GO:0016363) |
0.7 | 1.4 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.7 | 4.7 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.7 | 7.4 | GO:0005795 | Golgi stack(GO:0005795) |
0.7 | 6.0 | GO:0035861 | site of double-strand break(GO:0035861) |
0.7 | 3.3 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.7 | 6.6 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.7 | 1.3 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.7 | 0.7 | GO:0045259 | proton-transporting ATP synthase complex(GO:0045259) |
0.7 | 6.6 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.7 | 9.8 | GO:0034451 | centriolar satellite(GO:0034451) |
0.6 | 4.5 | GO:0070652 | HAUS complex(GO:0070652) |
0.6 | 1.3 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.6 | 4.5 | GO:0060091 | kinocilium(GO:0060091) |
0.6 | 1.3 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.6 | 1.9 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.6 | 37.6 | GO:0005604 | basement membrane(GO:0005604) |
0.6 | 48.0 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.6 | 5.0 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.6 | 2.5 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.6 | 2.5 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.6 | 2.4 | GO:0000812 | Swr1 complex(GO:0000812) |
0.6 | 9.1 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.6 | 1.8 | GO:0042825 | TAP complex(GO:0042825) |
0.6 | 5.4 | GO:0032797 | SMN complex(GO:0032797) |
0.6 | 1.8 | GO:0005955 | calcineurin complex(GO:0005955) |
0.6 | 3.6 | GO:0001520 | outer dense fiber(GO:0001520) |
0.6 | 0.6 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.6 | 2.4 | GO:0051233 | spindle midzone(GO:0051233) |
0.6 | 84.1 | GO:0031965 | nuclear membrane(GO:0031965) |
0.6 | 6.0 | GO:0033391 | chromatoid body(GO:0033391) |
0.6 | 0.6 | GO:0005683 | U7 snRNP(GO:0005683) |
0.6 | 6.5 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.6 | 0.6 | GO:0044391 | ribosomal subunit(GO:0044391) |
0.6 | 2.9 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.6 | 27.2 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.6 | 175.1 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.6 | 6.3 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.6 | 3.3 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.6 | 1.1 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.6 | 23.3 | GO:0030496 | midbody(GO:0030496) |
0.6 | 3.3 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.5 | 3.8 | GO:0032994 | protein-lipid complex(GO:0032994) |
0.5 | 15.9 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.5 | 0.5 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.5 | 9.8 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.5 | 2.7 | GO:0031415 | NatA complex(GO:0031415) |
0.5 | 69.5 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.5 | 1.6 | GO:0000346 | transcription export complex(GO:0000346) |
0.5 | 3.7 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.5 | 1.1 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.5 | 2.1 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.5 | 24.8 | GO:0016607 | nuclear speck(GO:0016607) |
0.5 | 26.7 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.5 | 6.7 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.5 | 1.0 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.5 | 1.0 | GO:0002177 | manchette(GO:0002177) |
0.5 | 1.5 | GO:0005796 | Golgi lumen(GO:0005796) |
0.5 | 1.5 | GO:0044448 | cell cortex part(GO:0044448) |
0.5 | 1.0 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.5 | 4.4 | GO:0001527 | microfibril(GO:0001527) |
0.5 | 4.4 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.5 | 5.3 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.5 | 2.4 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.5 | 1.9 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.5 | 1.9 | GO:0001939 | female pronucleus(GO:0001939) |
0.5 | 55.4 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.5 | 18.8 | GO:0000776 | kinetochore(GO:0000776) |
0.5 | 19.3 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.5 | 1.4 | GO:0005745 | m-AAA complex(GO:0005745) |
0.4 | 6.3 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.4 | 111.1 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.4 | 2.7 | GO:0032426 | stereocilium tip(GO:0032426) |
0.4 | 0.9 | GO:1990923 | PET complex(GO:1990923) |
0.4 | 13.3 | GO:0016604 | nuclear body(GO:0016604) |
0.4 | 12.0 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.4 | 0.9 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.4 | 1.3 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.4 | 683.8 | GO:0070062 | extracellular exosome(GO:0070062) |
0.4 | 0.4 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.4 | 0.9 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.4 | 1.7 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.4 | 0.8 | GO:0098536 | deuterosome(GO:0098536) |
0.4 | 0.4 | GO:0089701 | U2AF(GO:0089701) |
0.4 | 3.2 | GO:0061695 | transferase complex, transferring phosphorus-containing groups(GO:0061695) |
0.4 | 2.4 | GO:0045171 | intercellular bridge(GO:0045171) |
0.4 | 1.2 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.4 | 0.8 | GO:0071797 | LUBAC complex(GO:0071797) |
0.4 | 2.3 | GO:0000428 | DNA-directed RNA polymerase complex(GO:0000428) nuclear DNA-directed RNA polymerase complex(GO:0055029) |
0.4 | 8.0 | GO:0005657 | replication fork(GO:0005657) |
0.4 | 0.4 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.4 | 1.8 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.4 | 1.1 | GO:0030914 | STAGA complex(GO:0030914) |
0.3 | 0.7 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.3 | 3.1 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.3 | 3.7 | GO:0005776 | autophagosome(GO:0005776) |
0.3 | 1.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.3 | 0.7 | GO:0030897 | HOPS complex(GO:0030897) |
0.3 | 0.3 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
0.3 | 9.0 | GO:0044853 | plasma membrane raft(GO:0044853) |
0.3 | 0.6 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.3 | 259.1 | GO:0005654 | nucleoplasm(GO:0005654) |
0.3 | 0.3 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.3 | 8.5 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.3 | 0.3 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.3 | 24.9 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.3 | 1.2 | GO:0036128 | CatSper complex(GO:0036128) |
0.3 | 1.8 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.3 | 3.1 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.3 | 1.4 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.3 | 0.3 | GO:0070469 | respiratory chain(GO:0070469) |
0.3 | 0.5 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.3 | 3.9 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.3 | 0.3 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.2 | 0.2 | GO:0030684 | preribosome(GO:0030684) |
0.2 | 48.3 | GO:0005730 | nucleolus(GO:0005730) |
0.2 | 0.4 | GO:0035838 | growing cell tip(GO:0035838) |
0.2 | 0.4 | GO:0005869 | dynactin complex(GO:0005869) |
0.2 | 0.4 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.2 | 0.6 | GO:0071547 | piP-body(GO:0071547) |
0.2 | 0.2 | GO:0045120 | pronucleus(GO:0045120) |
0.2 | 1.4 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.2 | 0.5 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.2 | 1.0 | GO:0097546 | ciliary base(GO:0097546) |
0.2 | 0.5 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.2 | 0.5 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.2 | 1.6 | GO:0032420 | stereocilium(GO:0032420) |
0.2 | 0.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 0.8 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.1 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 12.2 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 68.7 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 18.9 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.1 | 0.2 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.1 | 1.7 | GO:0036126 | sperm flagellum(GO:0036126) |
0.1 | 14.7 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 4.8 | GO:0005694 | chromosome(GO:0005694) |
0.1 | 1.0 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.1 | GO:1990391 | DNA repair complex(GO:1990391) |
0.1 | 2.8 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 0.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.7 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.0 | 0.1 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 0.4 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 5.7 | GO:0005829 | cytosol(GO:0005829) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.3 | 51.7 | GO:0051525 | NFAT protein binding(GO:0051525) |
8.5 | 34.0 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
8.3 | 25.0 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
7.8 | 31.1 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
7.2 | 50.4 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
7.0 | 21.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
6.7 | 20.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
6.4 | 38.2 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
6.0 | 24.0 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
6.0 | 18.0 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
5.9 | 17.6 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
5.8 | 17.4 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
5.8 | 29.0 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
5.5 | 16.6 | GO:0004064 | arylesterase activity(GO:0004064) |
5.5 | 16.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
5.5 | 22.0 | GO:0015265 | urea channel activity(GO:0015265) |
5.5 | 16.4 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
5.5 | 21.9 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
5.2 | 21.0 | GO:0031720 | haptoglobin binding(GO:0031720) |
5.1 | 20.3 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
4.9 | 14.6 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
4.9 | 14.6 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
4.8 | 14.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
4.7 | 9.4 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
4.7 | 14.0 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
4.7 | 18.7 | GO:0051425 | PTB domain binding(GO:0051425) |
4.6 | 13.7 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
4.5 | 13.6 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
4.4 | 39.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
4.4 | 26.4 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
4.4 | 13.1 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
4.4 | 26.2 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
4.4 | 13.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
4.4 | 17.4 | GO:0002060 | purine nucleobase binding(GO:0002060) |
4.2 | 12.7 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
4.2 | 12.7 | GO:0031433 | telethonin binding(GO:0031433) |
4.2 | 50.5 | GO:0017166 | vinculin binding(GO:0017166) |
4.1 | 49.6 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
4.1 | 16.4 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
4.0 | 12.0 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
4.0 | 4.0 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
3.9 | 11.7 | GO:0035877 | death effector domain binding(GO:0035877) |
3.8 | 15.3 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
3.8 | 49.6 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
3.8 | 15.2 | GO:0034547 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
3.6 | 21.8 | GO:0008199 | ferric iron binding(GO:0008199) |
3.5 | 42.6 | GO:0005523 | tropomyosin binding(GO:0005523) |
3.5 | 21.1 | GO:0001727 | lipid kinase activity(GO:0001727) |
3.5 | 13.9 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
3.5 | 7.0 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
3.4 | 13.7 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
3.4 | 13.6 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
3.4 | 3.4 | GO:0070051 | fibrinogen binding(GO:0070051) |
3.3 | 70.2 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
3.3 | 13.0 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
3.2 | 3.2 | GO:0070644 | vitamin D response element binding(GO:0070644) |
3.2 | 28.9 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
3.2 | 35.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
3.2 | 18.9 | GO:0008432 | JUN kinase binding(GO:0008432) |
3.2 | 6.3 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
3.1 | 12.5 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
3.1 | 9.3 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
3.1 | 9.3 | GO:0030350 | iron-responsive element binding(GO:0030350) |
3.1 | 12.3 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
3.1 | 6.1 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
3.1 | 9.2 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
3.0 | 9.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
3.0 | 24.2 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
3.0 | 24.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
3.0 | 8.9 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
3.0 | 3.0 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
2.9 | 11.8 | GO:0009374 | biotin binding(GO:0009374) |
2.9 | 8.8 | GO:0019862 | IgA binding(GO:0019862) |
2.9 | 8.7 | GO:0038181 | bile acid receptor activity(GO:0038181) |
2.9 | 11.6 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
2.9 | 14.4 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
2.9 | 37.2 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
2.8 | 25.4 | GO:0031432 | titin binding(GO:0031432) |
2.8 | 11.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
2.8 | 8.4 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
2.8 | 8.4 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
2.7 | 13.7 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
2.7 | 8.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
2.7 | 8.1 | GO:0070412 | R-SMAD binding(GO:0070412) |
2.7 | 10.8 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
2.7 | 2.7 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
2.7 | 5.4 | GO:0048030 | disaccharide binding(GO:0048030) |
2.7 | 10.7 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
2.7 | 8.0 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
2.7 | 26.6 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
2.6 | 15.9 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
2.6 | 2.6 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
2.6 | 10.4 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
2.5 | 30.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
2.5 | 17.8 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
2.5 | 22.8 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
2.5 | 43.1 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
2.5 | 7.6 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
2.5 | 25.0 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
2.5 | 12.5 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
2.5 | 47.2 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
2.5 | 7.4 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
2.5 | 2.5 | GO:0005522 | profilin binding(GO:0005522) |
2.5 | 7.4 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
2.4 | 7.3 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
2.4 | 7.3 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
2.4 | 19.3 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
2.4 | 86.5 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
2.4 | 9.5 | GO:0015057 | thrombin receptor activity(GO:0015057) |
2.4 | 21.3 | GO:0044548 | S100 protein binding(GO:0044548) |
2.4 | 7.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
2.4 | 7.1 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
2.3 | 9.3 | GO:0043515 | kinetochore binding(GO:0043515) |
2.3 | 2.3 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
2.3 | 11.5 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
2.3 | 16.0 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
2.3 | 22.8 | GO:0008307 | structural constituent of muscle(GO:0008307) |
2.2 | 17.9 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
2.2 | 13.4 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
2.2 | 2.2 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
2.2 | 22.2 | GO:0003993 | acid phosphatase activity(GO:0003993) |
2.2 | 19.9 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
2.2 | 6.6 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
2.2 | 15.4 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
2.2 | 24.1 | GO:0005123 | death receptor binding(GO:0005123) |
2.2 | 8.8 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
2.2 | 4.3 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
2.2 | 19.5 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
2.2 | 8.6 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
2.1 | 10.7 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
2.1 | 2.1 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
2.1 | 6.4 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
2.1 | 8.5 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
2.1 | 2.1 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
2.1 | 6.3 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
2.1 | 6.3 | GO:0019770 | IgG receptor activity(GO:0019770) |
2.1 | 2.1 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
2.1 | 6.2 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
2.1 | 4.1 | GO:0050897 | cobalt ion binding(GO:0050897) |
2.1 | 14.4 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
2.0 | 8.2 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
2.0 | 6.1 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
2.0 | 8.1 | GO:0030984 | kininogen binding(GO:0030984) |
2.0 | 14.0 | GO:0019957 | C-C chemokine binding(GO:0019957) |
2.0 | 2.0 | GO:0019956 | chemokine binding(GO:0019956) |
2.0 | 31.8 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
2.0 | 6.0 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
2.0 | 9.9 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
2.0 | 4.0 | GO:0034618 | arginine binding(GO:0034618) |
2.0 | 53.3 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
2.0 | 3.9 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
1.9 | 7.7 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
1.9 | 1.9 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
1.9 | 11.5 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
1.9 | 23.0 | GO:0042288 | MHC class I protein binding(GO:0042288) |
1.9 | 5.7 | GO:0031013 | troponin I binding(GO:0031013) |
1.9 | 11.5 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
1.9 | 5.7 | GO:0042609 | CD4 receptor binding(GO:0042609) |
1.9 | 7.6 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
1.9 | 13.2 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
1.9 | 5.6 | GO:0030274 | LIM domain binding(GO:0030274) |
1.9 | 3.8 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
1.9 | 7.5 | GO:0038132 | neuregulin binding(GO:0038132) |
1.9 | 1.9 | GO:0035939 | microsatellite binding(GO:0035939) |
1.9 | 7.4 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
1.8 | 7.4 | GO:0043559 | insulin binding(GO:0043559) |
1.8 | 7.4 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
1.8 | 5.5 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
1.8 | 5.5 | GO:0009041 | uridylate kinase activity(GO:0009041) |
1.8 | 5.5 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
1.8 | 5.5 | GO:1990460 | leptin receptor binding(GO:1990460) |
1.8 | 5.5 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
1.8 | 32.8 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
1.8 | 3.6 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
1.8 | 18.0 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
1.8 | 28.7 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
1.8 | 5.3 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
1.8 | 3.6 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
1.8 | 28.4 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
1.8 | 15.9 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
1.8 | 26.4 | GO:0017049 | GTP-Rho binding(GO:0017049) |
1.7 | 5.2 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
1.7 | 5.1 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
1.7 | 10.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
1.7 | 32.3 | GO:0033613 | activating transcription factor binding(GO:0033613) |
1.7 | 5.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
1.7 | 5.0 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
1.7 | 1.7 | GO:0070411 | I-SMAD binding(GO:0070411) |
1.6 | 4.9 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
1.6 | 47.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
1.6 | 1.6 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
1.6 | 11.3 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
1.6 | 4.9 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
1.6 | 3.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
1.6 | 1.6 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
1.6 | 6.4 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
1.6 | 23.9 | GO:0008143 | poly(A) binding(GO:0008143) |
1.6 | 68.4 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
1.6 | 36.6 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
1.6 | 9.5 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
1.6 | 7.9 | GO:0070061 | fructose binding(GO:0070061) |
1.6 | 6.3 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
1.6 | 7.9 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
1.6 | 29.8 | GO:0043531 | ADP binding(GO:0043531) |
1.6 | 6.3 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
1.6 | 7.8 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
1.6 | 3.1 | GO:0035173 | histone kinase activity(GO:0035173) |
1.6 | 1.6 | GO:0051373 | FATZ binding(GO:0051373) |
1.6 | 3.1 | GO:0042834 | peptidoglycan binding(GO:0042834) |
1.6 | 26.5 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
1.6 | 4.7 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
1.6 | 6.2 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
1.6 | 6.2 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
1.6 | 7.8 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
1.5 | 20.1 | GO:0034185 | apolipoprotein binding(GO:0034185) |
1.5 | 9.3 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
1.5 | 12.3 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
1.5 | 7.7 | GO:0000405 | bubble DNA binding(GO:0000405) |
1.5 | 6.1 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
1.5 | 15.3 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
1.5 | 4.6 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
1.5 | 6.1 | GO:0052796 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
1.5 | 3.0 | GO:1904288 | BAT3 complex binding(GO:1904288) |
1.5 | 9.1 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
1.5 | 7.6 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
1.5 | 54.0 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
1.5 | 15.0 | GO:0051787 | misfolded protein binding(GO:0051787) |
1.5 | 3.0 | GO:0043426 | MRF binding(GO:0043426) |
1.5 | 4.5 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
1.5 | 4.5 | GO:0043199 | sulfate binding(GO:0043199) |
1.5 | 17.9 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
1.5 | 4.5 | GO:0008142 | oxysterol binding(GO:0008142) |
1.5 | 14.8 | GO:0034869 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
1.5 | 32.4 | GO:0001221 | transcription cofactor binding(GO:0001221) |
1.5 | 8.8 | GO:0039706 | co-receptor binding(GO:0039706) |
1.5 | 4.4 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
1.4 | 4.3 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
1.4 | 5.7 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
1.4 | 4.3 | GO:0055100 | adiponectin binding(GO:0055100) |
1.4 | 2.9 | GO:0070324 | thyroid hormone binding(GO:0070324) |
1.4 | 8.4 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
1.4 | 4.2 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
1.4 | 5.6 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
1.4 | 1.4 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
1.4 | 8.4 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
1.4 | 1.4 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
1.4 | 12.5 | GO:0070700 | BMP receptor binding(GO:0070700) |
1.4 | 6.9 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
1.4 | 6.9 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
1.4 | 9.7 | GO:0003896 | DNA primase activity(GO:0003896) |
1.4 | 2.8 | GO:0045340 | mercury ion binding(GO:0045340) |
1.4 | 2.7 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
1.4 | 1.4 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
1.4 | 10.8 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
1.4 | 5.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
1.3 | 6.7 | GO:0050786 | RAGE receptor binding(GO:0050786) |
1.3 | 5.4 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
1.3 | 22.9 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
1.3 | 6.7 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
1.3 | 2.7 | GO:0050692 | DBD domain binding(GO:0050692) |
1.3 | 1.3 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
1.3 | 6.6 | GO:0042015 | interleukin-20 binding(GO:0042015) |
1.3 | 7.9 | GO:0004622 | lysophospholipase activity(GO:0004622) |
1.3 | 19.8 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
1.3 | 11.8 | GO:0004017 | adenylate kinase activity(GO:0004017) |
1.3 | 1.3 | GO:0016418 | S-acetyltransferase activity(GO:0016418) dihydrolipoamide S-acyltransferase activity(GO:0030523) |
1.3 | 3.9 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
1.3 | 1.3 | GO:0003696 | satellite DNA binding(GO:0003696) |
1.3 | 3.9 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
1.3 | 3.9 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
1.3 | 2.6 | GO:0042887 | amide transmembrane transporter activity(GO:0042887) peptide transmembrane transporter activity(GO:1904680) |
1.3 | 3.9 | GO:0019959 | interleukin-8 binding(GO:0019959) |
1.3 | 2.6 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
1.3 | 7.8 | GO:0048406 | nerve growth factor binding(GO:0048406) |
1.3 | 10.4 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
1.3 | 5.2 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
1.3 | 7.8 | GO:0015288 | porin activity(GO:0015288) |
1.3 | 6.5 | GO:0016151 | nickel cation binding(GO:0016151) |
1.3 | 6.5 | GO:0035174 | histone serine kinase activity(GO:0035174) |
1.3 | 7.7 | GO:0050700 | CARD domain binding(GO:0050700) |
1.3 | 3.9 | GO:0036033 | mediator complex binding(GO:0036033) |
1.3 | 6.4 | GO:0035473 | lipase binding(GO:0035473) |
1.3 | 2.6 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
1.3 | 2.6 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
1.3 | 3.8 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
1.3 | 12.7 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
1.3 | 5.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
1.3 | 29.1 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
1.3 | 2.5 | GO:0033142 | progesterone receptor binding(GO:0033142) |
1.3 | 3.8 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
1.3 | 5.0 | GO:0042731 | PH domain binding(GO:0042731) |
1.3 | 8.8 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
1.3 | 3.8 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
1.2 | 5.0 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
1.2 | 12.4 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
1.2 | 7.4 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
1.2 | 2.5 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
1.2 | 3.7 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
1.2 | 6.1 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
1.2 | 1.2 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
1.2 | 7.3 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
1.2 | 26.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
1.2 | 12.1 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
1.2 | 6.0 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
1.2 | 6.0 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
1.2 | 14.4 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
1.2 | 10.8 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
1.2 | 3.6 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
1.2 | 8.3 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
1.2 | 17.8 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
1.2 | 7.1 | GO:0034046 | poly(G) binding(GO:0034046) |
1.2 | 4.8 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
1.2 | 7.1 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
1.2 | 8.3 | GO:0018446 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
1.2 | 3.5 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
1.2 | 3.5 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
1.2 | 1.2 | GO:0034452 | dynactin binding(GO:0034452) |
1.2 | 4.7 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
1.2 | 2.3 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
1.2 | 3.5 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
1.2 | 2.3 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
1.2 | 9.2 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
1.1 | 8.0 | GO:0070513 | death domain binding(GO:0070513) |
1.1 | 17.1 | GO:0001848 | complement binding(GO:0001848) |
1.1 | 37.6 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
1.1 | 3.4 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
1.1 | 2.3 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
1.1 | 4.5 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
1.1 | 1.1 | GO:0070878 | primary miRNA binding(GO:0070878) |
1.1 | 2.2 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
1.1 | 1.1 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
1.1 | 6.7 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
1.1 | 2.2 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
1.1 | 3.3 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
1.1 | 1.1 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
1.1 | 3.3 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
1.1 | 3.3 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
1.1 | 5.5 | GO:0071253 | connexin binding(GO:0071253) |
1.1 | 3.3 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
1.1 | 3.3 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
1.1 | 17.6 | GO:0042805 | actinin binding(GO:0042805) |
1.1 | 4.4 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
1.1 | 6.4 | GO:0008301 | DNA binding, bending(GO:0008301) |
1.1 | 2.1 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
1.0 | 4.2 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
1.0 | 3.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
1.0 | 3.1 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
1.0 | 9.4 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
1.0 | 3.1 | GO:0071209 | U7 snRNA binding(GO:0071209) |
1.0 | 4.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
1.0 | 4.1 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
1.0 | 2.0 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
1.0 | 5.1 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
1.0 | 3.0 | GO:0004104 | cholinesterase activity(GO:0004104) |
1.0 | 3.0 | GO:0004359 | glutaminase activity(GO:0004359) |
1.0 | 4.0 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
1.0 | 11.0 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
1.0 | 1.0 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
1.0 | 2.0 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
1.0 | 4.0 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
1.0 | 1.0 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
1.0 | 4.0 | GO:0019808 | polyamine binding(GO:0019808) |
1.0 | 2.0 | GO:0004096 | catalase activity(GO:0004096) |
1.0 | 8.9 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
1.0 | 10.9 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
1.0 | 6.9 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
1.0 | 11.8 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
1.0 | 6.9 | GO:0003688 | DNA replication origin binding(GO:0003688) |
1.0 | 2.9 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
1.0 | 5.9 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
1.0 | 9.7 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
1.0 | 7.8 | GO:0031996 | thioesterase binding(GO:0031996) |
1.0 | 4.8 | GO:0005113 | patched binding(GO:0005113) |
1.0 | 5.8 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
1.0 | 2.9 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
1.0 | 4.8 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
1.0 | 2.9 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
1.0 | 4.8 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
1.0 | 2.9 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
1.0 | 4.8 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.9 | 0.9 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.9 | 47.3 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.9 | 6.6 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.9 | 1.9 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.9 | 6.6 | GO:0052813 | phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.9 | 3.8 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.9 | 7.5 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.9 | 10.3 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.9 | 0.9 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.9 | 1.9 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.9 | 26.0 | GO:0015485 | cholesterol binding(GO:0015485) |
0.9 | 2.8 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.9 | 2.8 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.9 | 5.5 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.9 | 3.7 | GO:0052744 | phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
0.9 | 4.6 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.9 | 21.0 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.9 | 4.5 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.9 | 1.8 | GO:0051870 | methotrexate binding(GO:0051870) |
0.9 | 8.2 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.9 | 4.5 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.9 | 6.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.9 | 5.4 | GO:0016936 | galactoside binding(GO:0016936) |
0.9 | 0.9 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.9 | 0.9 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.9 | 1.8 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.9 | 0.9 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.9 | 0.9 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.9 | 5.3 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.9 | 12.5 | GO:0045296 | cadherin binding(GO:0045296) |
0.9 | 4.5 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.9 | 2.7 | GO:0051734 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.9 | 8.0 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.9 | 1.8 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.9 | 2.7 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.9 | 3.5 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.9 | 2.6 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.9 | 59.8 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.9 | 2.6 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.9 | 1.8 | GO:0070728 | leucine binding(GO:0070728) |
0.9 | 7.9 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.9 | 42.9 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.9 | 0.9 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.9 | 5.2 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.9 | 8.7 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.9 | 5.2 | GO:0018741 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.9 | 9.5 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.9 | 2.6 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.9 | 2.6 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.9 | 46.4 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.9 | 9.4 | GO:0005521 | lamin binding(GO:0005521) |
0.8 | 138.5 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.8 | 8.5 | GO:0004568 | chitinase activity(GO:0004568) |
0.8 | 3.4 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.8 | 1.7 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.8 | 5.9 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.8 | 0.8 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.8 | 5.0 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.8 | 15.9 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.8 | 2.5 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.8 | 5.8 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.8 | 9.1 | GO:0016684 | oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.8 | 3.3 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.8 | 1.7 | GO:0015250 | water transmembrane transporter activity(GO:0005372) water channel activity(GO:0015250) |
0.8 | 24.0 | GO:0030145 | manganese ion binding(GO:0030145) |
0.8 | 3.3 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.8 | 8.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.8 | 7.4 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.8 | 0.8 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.8 | 125.1 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.8 | 11.3 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.8 | 4.0 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.8 | 2.4 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.8 | 2.4 | GO:0008494 | translation activator activity(GO:0008494) |
0.8 | 1.6 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.8 | 8.8 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.8 | 2.4 | GO:0038100 | nodal binding(GO:0038100) |
0.8 | 13.5 | GO:0001968 | fibronectin binding(GO:0001968) |
0.8 | 23.7 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.8 | 5.5 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.8 | 4.7 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.8 | 1.6 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.8 | 6.3 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.8 | 1.6 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.8 | 4.7 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.8 | 10.9 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.8 | 10.9 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.8 | 38.8 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.8 | 3.1 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.8 | 4.6 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.8 | 2.3 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.8 | 5.4 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.8 | 2.3 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.8 | 1.5 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.8 | 18.3 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.8 | 16.0 | GO:0005537 | mannose binding(GO:0005537) |
0.8 | 2.3 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.8 | 9.1 | GO:0001618 | virus receptor activity(GO:0001618) |
0.8 | 3.0 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.7 | 7.5 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.7 | 30.4 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.7 | 2.2 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.7 | 2.9 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.7 | 9.5 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.7 | 1.5 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.7 | 12.4 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.7 | 1.5 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.7 | 0.7 | GO:0019213 | deacetylase activity(GO:0019213) |
0.7 | 2.2 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.7 | 11.6 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.7 | 14.5 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.7 | 0.7 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.7 | 13.7 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.7 | 18.0 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.7 | 7.9 | GO:0071949 | FAD binding(GO:0071949) |
0.7 | 2.9 | GO:0033691 | sialic acid binding(GO:0033691) |
0.7 | 2.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.7 | 2.1 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.7 | 0.7 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.7 | 6.4 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.7 | 1.4 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.7 | 1.4 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.7 | 6.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.7 | 0.7 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.7 | 4.9 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.7 | 2.1 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.7 | 4.8 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.7 | 6.8 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.7 | 16.9 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.7 | 5.4 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.7 | 54.3 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.7 | 3.3 | GO:0005536 | glucose binding(GO:0005536) |
0.7 | 12.7 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.7 | 0.7 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.7 | 0.7 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.7 | 8.0 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.7 | 3.3 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.7 | 6.5 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.6 | 0.6 | GO:0050693 | LBD domain binding(GO:0050693) |
0.6 | 1.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.6 | 9.6 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.6 | 3.8 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.6 | 1.3 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.6 | 0.6 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.6 | 0.6 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.6 | 0.6 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.6 | 1.9 | GO:0000182 | rDNA binding(GO:0000182) |
0.6 | 3.1 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.6 | 23.1 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.6 | 2.5 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.6 | 5.0 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.6 | 1.2 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.6 | 0.6 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.6 | 1.9 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.6 | 40.8 | GO:0005178 | integrin binding(GO:0005178) |
0.6 | 1.8 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.6 | 18.4 | GO:0005507 | copper ion binding(GO:0005507) |
0.6 | 3.0 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.6 | 2.4 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.6 | 3.0 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.6 | 7.9 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.6 | 3.6 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.6 | 3.6 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.6 | 1.8 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.6 | 71.0 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.6 | 1.8 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.6 | 1.8 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.6 | 2.4 | GO:0098505 | single-stranded telomeric DNA binding(GO:0043047) G-rich strand telomeric DNA binding(GO:0098505) |
0.6 | 11.8 | GO:0015645 | fatty acid ligase activity(GO:0015645) |
0.6 | 2.3 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.6 | 1.8 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.6 | 3.5 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.6 | 1.2 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.6 | 5.2 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.6 | 20.1 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.6 | 2.3 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.6 | 1.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.6 | 0.6 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.6 | 2.3 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.6 | 0.6 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
0.6 | 2.8 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.6 | 9.0 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.6 | 20.7 | GO:0016876 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.6 | 2.2 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.6 | 4.5 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.6 | 1.7 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.6 | 1.7 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.6 | 0.6 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.5 | 13.7 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.5 | 17.0 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.5 | 2.2 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.5 | 1.6 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.5 | 14.7 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.5 | 1.1 | GO:0000339 | RNA cap binding(GO:0000339) |
0.5 | 3.7 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.5 | 5.3 | GO:0031491 | nucleosome binding(GO:0031491) |
0.5 | 0.5 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.5 | 1.1 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.5 | 42.6 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.5 | 2.1 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.5 | 16.7 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.5 | 1.6 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
0.5 | 16.6 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.5 | 0.5 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.5 | 3.0 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.5 | 1.0 | GO:0019961 | interferon binding(GO:0019961) |
0.5 | 3.0 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.5 | 3.0 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.5 | 0.5 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.5 | 0.5 | GO:0016428 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.5 | 3.9 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.5 | 6.9 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.5 | 1.0 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.5 | 1.5 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.5 | 12.2 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.5 | 1.9 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.5 | 10.7 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.5 | 12.1 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.5 | 14.4 | GO:0060090 | binding, bridging(GO:0060090) |
0.5 | 1.0 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.5 | 3.4 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.5 | 1.4 | GO:0019002 | GMP binding(GO:0019002) |
0.5 | 1.4 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.5 | 3.3 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.5 | 16.5 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.5 | 1.4 | GO:0004854 | aldehyde oxidase activity(GO:0004031) xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.5 | 4.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.5 | 0.9 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.5 | 13.9 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.5 | 14.3 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.5 | 1.4 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.5 | 0.5 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.5 | 4.1 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.5 | 1.8 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.5 | 5.9 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.4 | 10.3 | GO:0051287 | NAD binding(GO:0051287) |
0.4 | 0.4 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.4 | 1.3 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.4 | 2.2 | GO:0050733 | RS domain binding(GO:0050733) |
0.4 | 2.2 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.4 | 0.4 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.4 | 1.7 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.4 | 1.3 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) methionine-R-sulfoxide reductase activity(GO:0070191) |
0.4 | 0.8 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.4 | 0.4 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.4 | 6.3 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.4 | 1.7 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.4 | 12.9 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.4 | 2.5 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.4 | 0.8 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.4 | 0.4 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.4 | 1.2 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.4 | 0.8 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.4 | 0.8 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.4 | 71.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.4 | 0.4 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.4 | 1.6 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.4 | 0.4 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.4 | 0.8 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.4 | 0.8 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.4 | 1.2 | GO:0034584 | piRNA binding(GO:0034584) |
0.4 | 1.2 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.4 | 0.4 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.4 | 4.3 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.4 | 3.1 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.4 | 63.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.4 | 1.2 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) |
0.4 | 6.5 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.4 | 2.6 | GO:0030955 | potassium ion binding(GO:0030955) |
0.4 | 0.4 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.4 | 11.0 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.4 | 3.8 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.4 | 4.9 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.4 | 7.1 | GO:0000049 | tRNA binding(GO:0000049) |
0.4 | 0.4 | GO:0030519 | snoRNP binding(GO:0030519) |
0.4 | 4.0 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.4 | 10.9 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.4 | 1.1 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.4 | 28.6 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.4 | 0.4 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.4 | 1.4 | GO:0016416 | O-palmitoyltransferase activity(GO:0016416) |
0.4 | 3.2 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.4 | 0.4 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.4 | 0.7 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.3 | 2.8 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.3 | 4.2 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.3 | 0.3 | GO:0035870 | dITP diphosphatase activity(GO:0035870) |
0.3 | 1.4 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.3 | 3.1 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.3 | 16.9 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.3 | 1.0 | GO:0008430 | selenium binding(GO:0008430) |
0.3 | 1.4 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.3 | 0.3 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.3 | 1.4 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.3 | 0.7 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.3 | 5.0 | GO:0045502 | dynein binding(GO:0045502) |
0.3 | 0.7 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.3 | 0.7 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.3 | 7.4 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.3 | 1.6 | GO:0043274 | phospholipase binding(GO:0043274) |
0.3 | 1.3 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.3 | 0.6 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.3 | 0.9 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.3 | 4.1 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.3 | 1.3 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.3 | 1.6 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.3 | 0.3 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.3 | 2.2 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.3 | 0.9 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.3 | 2.8 | GO:0015643 | toxic substance binding(GO:0015643) |
0.3 | 0.9 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.3 | 1.2 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.3 | 0.3 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.3 | 0.6 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.3 | 0.9 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.3 | 30.1 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.3 | 1.8 | GO:0016209 | antioxidant activity(GO:0016209) |
0.3 | 5.3 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.3 | 0.9 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.3 | 21.0 | GO:0004386 | helicase activity(GO:0004386) |
0.3 | 0.9 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.3 | 0.9 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.3 | 3.3 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.3 | 1.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.3 | 1.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.3 | 0.8 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.3 | 1.9 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.3 | 6.4 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.3 | 8.0 | GO:0035064 | methylated histone binding(GO:0035064) |
0.3 | 0.3 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.3 | 2.1 | GO:0016918 | retinal binding(GO:0016918) |
0.3 | 1.3 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.3 | 0.8 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.3 | 0.3 | GO:0032190 | acrosin binding(GO:0032190) |
0.3 | 0.8 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.3 | 3.8 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.2 | 3.5 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.2 | 2.0 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.2 | 1.0 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.2 | 0.7 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.2 | 1.0 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.2 | 1.9 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.2 | 1.9 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.2 | 0.2 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.2 | 8.8 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.2 | 4.9 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 9.2 | GO:0019003 | GDP binding(GO:0019003) |
0.2 | 0.7 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.2 | 0.7 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.2 | 1.6 | GO:0043236 | laminin binding(GO:0043236) |
0.2 | 0.2 | GO:0001846 | opsonin binding(GO:0001846) |
0.2 | 0.7 | GO:0035586 | purinergic receptor activity(GO:0035586) |
0.2 | 0.2 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.2 | 1.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.2 | 3.0 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.2 | 2.6 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 0.9 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.2 | 0.8 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.2 | 0.4 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.2 | 6.8 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.2 | 4.3 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.2 | 7.1 | GO:0004518 | nuclease activity(GO:0004518) |
0.2 | 1.6 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.2 | 0.2 | GO:0030580 | C-methyltransferase activity(GO:0008169) 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity(GO:0008425) quinone cofactor methyltransferase activity(GO:0030580) |
0.2 | 0.4 | GO:0031014 | troponin T binding(GO:0031014) |
0.2 | 0.4 | GO:1990188 | euchromatin binding(GO:1990188) |
0.2 | 0.8 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.2 | 0.9 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.2 | 0.9 | GO:0022884 | macromolecule transmembrane transporter activity(GO:0022884) |
0.2 | 4.4 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 0.2 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.2 | 0.5 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.2 | 5.2 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.2 | 0.5 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.2 | 0.3 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.2 | 9.4 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.2 | 0.6 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.2 | 0.6 | GO:0070628 | proteasome binding(GO:0070628) |
0.2 | 16.3 | GO:0016887 | ATPase activity(GO:0016887) |
0.2 | 0.2 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 0.7 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.1 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.3 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.7 | GO:0019239 | deaminase activity(GO:0019239) |
0.1 | 0.9 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.3 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.1 | 16.5 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.3 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 1.0 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.1 | 10.3 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.1 | 5.0 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.6 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.1 | 11.6 | GO:0005550 | pheromone binding(GO:0005550) |
0.1 | 0.4 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.4 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 2.1 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 0.6 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 3.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 4.2 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 0.1 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.1 | 0.3 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.1 | 1.1 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.1 | 2.8 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
0.1 | 0.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 0.9 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.1 | 4.6 | GO:0001047 | core promoter binding(GO:0001047) |
0.1 | 8.3 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.1 | 0.9 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 0.3 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 0.2 | GO:0070990 | snRNP binding(GO:0070990) |
0.1 | 0.2 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.1 | 0.4 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 3.2 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 0.2 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.1 | 1.1 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 0.1 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.1 | 0.3 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.3 | GO:0052849 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.1 | 0.6 | GO:0061134 | peptidase regulator activity(GO:0061134) |
0.1 | 0.7 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.1 | 0.2 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.1 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.1 | 0.2 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 0.2 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.0 | 0.7 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.0 | 0.0 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.0 | 0.6 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.7 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.7 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.2 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 0.0 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 4.0 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 0.1 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.0 | 20.9 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.0 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 1.0 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.6 | 6.6 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
3.8 | 123.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
3.8 | 129.1 | PID EPO PATHWAY | EPO signaling pathway |
3.7 | 3.7 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
3.6 | 153.9 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
2.8 | 51.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
2.8 | 2.8 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
2.8 | 118.7 | PID ILK PATHWAY | Integrin-linked kinase signaling |
2.8 | 36.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
2.7 | 115.1 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
2.7 | 13.5 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
2.6 | 18.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
2.6 | 28.6 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
2.5 | 66.1 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
2.4 | 111.5 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
2.4 | 14.5 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
2.4 | 2.4 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
2.4 | 30.9 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
2.3 | 11.7 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
2.3 | 52.0 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
2.2 | 13.5 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
2.2 | 56.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
2.2 | 57.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
2.2 | 6.6 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
2.2 | 94.2 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
2.2 | 13.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
2.1 | 25.8 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
2.1 | 56.5 | PID RHOA PATHWAY | RhoA signaling pathway |
2.0 | 8.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
2.0 | 17.9 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
1.9 | 56.1 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
1.9 | 21.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
1.9 | 47.0 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
1.9 | 44.9 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
1.9 | 14.9 | PID IGF1 PATHWAY | IGF1 pathway |
1.9 | 94.7 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
1.9 | 66.7 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
1.8 | 42.4 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
1.7 | 22.5 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
1.7 | 59.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
1.7 | 21.9 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
1.7 | 21.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
1.6 | 46.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
1.6 | 1.6 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
1.6 | 46.5 | PID IL12 2PATHWAY | IL12-mediated signaling events |
1.6 | 36.7 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
1.6 | 9.5 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
1.6 | 6.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
1.5 | 45.0 | PID PLK1 PATHWAY | PLK1 signaling events |
1.5 | 1.5 | ST GA12 PATHWAY | G alpha 12 Pathway |
1.5 | 19.0 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
1.4 | 72.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
1.4 | 24.3 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
1.4 | 25.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
1.4 | 8.1 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
1.3 | 17.5 | PID BCR 5PATHWAY | BCR signaling pathway |
1.3 | 49.7 | PID P73PATHWAY | p73 transcription factor network |
1.3 | 11.9 | PID ALK2 PATHWAY | ALK2 signaling events |
1.3 | 9.0 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
1.3 | 3.8 | PID CD40 PATHWAY | CD40/CD40L signaling |
1.3 | 5.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
1.3 | 16.3 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
1.2 | 19.9 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
1.2 | 14.7 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
1.2 | 13.4 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
1.2 | 2.4 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
1.2 | 9.7 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
1.2 | 15.6 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
1.2 | 8.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
1.2 | 5.9 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
1.2 | 1.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
1.2 | 4.7 | PID IFNG PATHWAY | IFN-gamma pathway |
1.2 | 18.6 | PID ATM PATHWAY | ATM pathway |
1.2 | 43.0 | PID CMYB PATHWAY | C-MYB transcription factor network |
1.2 | 10.4 | PID AURORA A PATHWAY | Aurora A signaling |
1.1 | 13.7 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
1.1 | 33.9 | PID E2F PATHWAY | E2F transcription factor network |
1.1 | 13.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
1.1 | 13.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
1.1 | 5.5 | PID IL2 1PATHWAY | IL2-mediated signaling events |
1.1 | 15.1 | PID RAS PATHWAY | Regulation of Ras family activation |
1.1 | 18.1 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
1.1 | 24.5 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
1.0 | 8.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
1.0 | 7.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
1.0 | 1.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
1.0 | 1.0 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
1.0 | 9.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
1.0 | 13.4 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
1.0 | 5.7 | PID ALK1 PATHWAY | ALK1 signaling events |
0.9 | 10.4 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.9 | 12.3 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.9 | 2.8 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.9 | 10.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.9 | 2.8 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.9 | 6.1 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.9 | 10.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.9 | 6.8 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.8 | 4.1 | PID ENDOTHELIN PATHWAY | Endothelins |
0.8 | 3.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.8 | 0.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.8 | 1.6 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.7 | 4.5 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.7 | 2.8 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.7 | 4.2 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.7 | 5.5 | PID INSULIN PATHWAY | Insulin Pathway |
0.7 | 9.3 | PID BARD1 PATHWAY | BARD1 signaling events |
0.6 | 8.2 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.6 | 0.6 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.6 | 9.6 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.5 | 3.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.5 | 10.2 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.5 | 96.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.5 | 0.5 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.5 | 2.9 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.5 | 0.5 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.5 | 0.5 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.5 | 3.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.5 | 6.9 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.4 | 4.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.4 | 0.4 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.4 | 22.4 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.4 | 7.6 | PID AURORA B PATHWAY | Aurora B signaling |
0.4 | 0.8 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.4 | 6.9 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.4 | 2.7 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.4 | 6.8 | PID FGF PATHWAY | FGF signaling pathway |
0.4 | 4.4 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.4 | 2.2 | PID ATR PATHWAY | ATR signaling pathway |
0.4 | 7.6 | PID P53 REGULATION PATHWAY | p53 pathway |
0.3 | 1.3 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.3 | 4.0 | PID ARF 3PATHWAY | Arf1 pathway |
0.3 | 3.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.3 | 2.2 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.3 | 3.6 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.3 | 2.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.3 | 4.6 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.2 | 0.5 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.2 | 0.7 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 1.1 | ST GAQ PATHWAY | G alpha q Pathway |
0.2 | 3.2 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.2 | 0.9 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 1.7 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 13.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 0.6 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 0.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 0.5 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.1 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.0 | 83.3 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
4.8 | 14.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
4.5 | 4.5 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
4.2 | 4.2 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
4.2 | 41.8 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
3.8 | 45.3 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
3.8 | 11.3 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
3.3 | 36.7 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
3.2 | 88.8 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
3.1 | 34.2 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
3.1 | 46.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
3.0 | 57.9 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
3.0 | 48.7 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
3.0 | 30.2 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
3.0 | 68.4 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
3.0 | 67.9 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
2.8 | 53.9 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
2.8 | 2.8 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
2.7 | 46.0 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
2.7 | 21.6 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
2.6 | 34.4 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
2.6 | 36.5 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
2.5 | 20.2 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
2.5 | 24.6 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
2.4 | 243.8 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
2.4 | 26.5 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
2.4 | 88.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
2.4 | 28.5 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
2.3 | 2.3 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
2.3 | 41.8 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
2.3 | 51.9 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
2.2 | 37.6 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
2.2 | 13.0 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
2.2 | 17.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
2.1 | 31.3 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
2.1 | 2.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
2.1 | 29.0 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
2.1 | 61.5 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
2.0 | 15.9 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
2.0 | 13.9 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
2.0 | 9.9 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
1.9 | 21.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
1.9 | 26.9 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
1.9 | 1.9 | REACTOME INNATE IMMUNE SYSTEM | Genes involved in Innate Immune System |
1.9 | 11.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
1.9 | 24.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
1.9 | 18.9 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
1.9 | 20.7 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
1.9 | 48.4 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
1.9 | 59.4 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
1.8 | 44.4 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
1.8 | 14.5 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
1.8 | 19.9 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
1.8 | 24.8 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
1.8 | 10.6 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
1.8 | 14.1 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
1.7 | 17.3 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
1.7 | 37.9 | REACTOME G1 PHASE | Genes involved in G1 Phase |
1.7 | 17.2 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
1.7 | 8.6 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
1.7 | 5.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
1.7 | 11.8 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
1.6 | 4.9 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
1.6 | 13.0 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
1.6 | 24.3 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
1.6 | 9.6 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
1.6 | 4.8 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
1.6 | 17.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
1.6 | 42.8 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
1.6 | 7.9 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
1.6 | 15.6 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
1.6 | 12.5 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
1.6 | 21.8 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
1.6 | 9.3 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
1.5 | 9.3 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
1.5 | 15.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
1.5 | 9.2 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
1.5 | 31.8 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
1.5 | 11.8 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
1.4 | 33.0 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
1.4 | 5.7 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
1.4 | 15.6 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
1.4 | 1.4 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
1.4 | 19.5 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
1.4 | 15.2 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
1.4 | 34.6 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
1.4 | 8.2 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
1.4 | 8.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
1.4 | 48.6 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
1.3 | 4.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
1.3 | 12.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
1.3 | 28.0 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
1.3 | 15.9 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
1.3 | 123.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
1.3 | 58.4 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
1.3 | 9.1 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
1.3 | 2.6 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
1.3 | 1.3 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
1.3 | 71.4 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
1.2 | 8.6 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
1.2 | 3.6 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
1.2 | 6.0 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
1.2 | 8.3 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
1.2 | 12.8 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
1.2 | 9.3 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
1.1 | 13.7 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
1.1 | 15.9 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
1.1 | 48.1 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
1.1 | 4.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
1.1 | 3.3 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
1.1 | 1.1 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
1.1 | 3.3 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
1.1 | 19.5 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
1.1 | 1.1 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
1.0 | 8.3 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
1.0 | 8.3 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
1.0 | 27.7 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
1.0 | 17.1 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
1.0 | 8.0 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
1.0 | 8.9 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
1.0 | 17.5 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
1.0 | 5.8 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
1.0 | 17.3 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
1.0 | 13.5 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
1.0 | 14.4 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
1.0 | 1.0 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.9 | 12.6 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.9 | 7.1 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.9 | 10.4 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.9 | 14.8 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.9 | 10.4 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.9 | 6.9 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.8 | 15.3 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.8 | 1.7 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.8 | 7.5 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.8 | 6.6 | REACTOME OPSINS | Genes involved in Opsins |
0.8 | 0.8 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.8 | 13.9 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.8 | 5.6 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.8 | 8.6 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.8 | 7.7 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.8 | 29.3 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.8 | 3.8 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.8 | 6.9 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.8 | 6.1 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.8 | 6.8 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.7 | 5.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.7 | 5.9 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.7 | 72.8 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.7 | 2.2 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.7 | 11.4 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.7 | 9.2 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.7 | 56.3 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.7 | 10.3 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.7 | 4.1 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.7 | 0.7 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.7 | 2.1 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.7 | 9.5 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.7 | 2.0 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.7 | 3.3 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.6 | 1.9 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.6 | 1.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.6 | 0.6 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.6 | 4.8 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.6 | 12.7 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.6 | 3.0 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.6 | 1.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.6 | 3.0 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.6 | 7.0 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.6 | 3.5 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.6 | 3.5 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.6 | 7.4 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.6 | 2.8 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.6 | 2.8 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.5 | 6.0 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.5 | 1.6 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.5 | 1.6 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.5 | 2.2 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.5 | 6.5 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.5 | 12.1 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.5 | 10.6 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.5 | 1.4 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.5 | 6.5 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.5 | 1.9 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.4 | 5.8 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.4 | 6.7 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.4 | 34.8 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.4 | 8.0 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.4 | 7.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.4 | 5.2 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.4 | 13.2 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.4 | 9.2 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.4 | 1.3 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.4 | 3.2 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.4 | 6.5 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.4 | 62.5 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.4 | 28.5 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
0.4 | 29.1 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.4 | 6.7 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.4 | 7.8 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.4 | 10.8 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.4 | 0.4 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.4 | 9.8 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.4 | 1.1 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.4 | 15.1 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.4 | 9.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.3 | 4.1 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.3 | 0.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.3 | 1.7 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.3 | 3.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.3 | 3.9 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.3 | 3.7 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.3 | 1.5 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.3 | 4.3 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.3 | 3.7 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.3 | 2.0 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.3 | 0.9 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.3 | 1.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.3 | 0.8 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.3 | 3.1 | REACTOME TRANSLATION | Genes involved in Translation |
0.3 | 2.6 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.3 | 6.8 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.3 | 4.8 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.2 | 2.0 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.2 | 4.7 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.2 | 9.0 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 1.4 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.2 | 2.6 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
0.2 | 0.2 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.2 | 2.0 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 8.9 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.2 | 0.9 | REACTOME DEFENSINS | Genes involved in Defensins |
0.2 | 1.3 | REACTOME HIV LIFE CYCLE | Genes involved in HIV Life Cycle |
0.2 | 1.0 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.2 | 1.5 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.2 | 4.1 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.2 | 4.9 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 0.3 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 1.6 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 0.5 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.1 | 0.4 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.1 | 1.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 0.8 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 0.1 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.1 | 0.1 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.0 | 0.0 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |